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Abstract Desmosomes are patch-like intercellular adher-
ing junctions (“maculae adherentes”), which, in concert
with the related adherens junctions, provide the mechanical
strength to intercellular adhesion. Therefore, it is not sur-
prising that desmosomes are abundant in tissues subjected
to signiWcant mechanical stress such as stratiWed epithelia
and myocardium. Desmosomal adhesion is based on the
Ca2+-dependent, homo- and heterophilic transinteraction of
cadherin-type adhesion molecules. Desmosomal cadherins
are anchored to the intermediate Wlament cytoskeleton by
adaptor proteins of the armadillo and plakin families. Des-
mosomes are dynamic structures subjected to regulation
and are therefore targets of signalling pathways, which con-
trol their molecular composition and adhesive properties.
Moreover, evidence is emerging that desmosomal compo-
nents themselves take part in outside-in signalling under
physiologic and pathologic conditions. Disturbed desmo-
somal adhesion contributes to the pathogenesis of a number
of diseases such as pemphigus, which is caused by autoan-
tibodies against desmosomal cadherins. Beside pemphigus,
desmosome-associated diseases are caused by other mecha-
nisms such as genetic defects or bacterial toxins. Because
most of these diseases aVect the skin, desmosomes are
interesting not only for cell biologists who are inspired by
their complex structure and molecular composition, but
also for clinical physicians who are confronted with
patients suVering from severe blistering skin diseases such
as pemphigus. To develop disease-speciWc therapeutic
approaches, more insights into the molecular composition
and regulation of desmosomes are required.
Keywords Desmosomes · Desmogleins · 
Pemphigus · Autoantibodies · Steric hindrance · 
Desmoglein compensation
Introduction
Desmosomes are intercellular adhering junctions serving to
attach neighbouring cells to each other. They are most
numerous in tissues subjected to signiWcant mechanical
stress such as the stratiWed squamous epithelia of the skin
(Bizzozero 1864) and of mucous membranes (Farquhar and
Palade  1963) as well as the myocardium (Fawcett and
Selby 1958). Moreover, desmosomes are found in simple
epithelia and in non-epithelial cells such as the meningeal
cells of the arachnoidea (Gusek 1962) and the follicular
dendritic cells of lymph follicles (Swartzendruber 1965).
Desmosomes were discovered as cell contacts in the
middle of the nineteenth century (Calkins and Setzer 2007).
By the means of light microscopy, desmosomes were Wrst
described in the epidermis by the Italian pathologist Bizzo-
zero in (1864). In his histology text book, the anatomist
Josef SchaVer from Vienna introduced the term “desmo-
some”, by combining the greek words “desmos” (bond) and
“soma” (body) although, to that time, he, like most others
in the Weld believed that desmosomes were cytoplasm-Wlled
intercellular bridges (SchaVer 1920). It took almost another
century until Keith Porter, using electron microscopy, was
able to conWrm the basic observation of Bizzozero that des-
mosomes rather are contacts between adjacent cells and to
J. Waschke
Institute of Anatomy and Cell Biology, University of Würzburg, 
Koellikerstr. 6, 97070 Würzburg, Germany
J. Waschke (&)
Institute of Anatomy and Cell Biology, 
Julius-Maximilians-University, Koellikerstr. 6, 
97070 Würzburg, Germany
e-mail: jens.waschke@mail.uni-wuerzburg.de22 Histochem Cell Biol (2008) 130:21–54
123
allow the Wrst description on desmosome ultrastructure
(Porter 1956). With these new technical advances at hand,
several studies were performed in the following years on
the distribution and organization of desmosomes in various
tissues. In addition, starting in the 1970s, biochemical
approaches and molecular cloning techniques were applied
to identify the desmosomal components and to characterize
their interactions (Drochmans et al. 1978; Moll et al. 1986;
Moll and Franke 1982; Schwarz et al. 1990; Skerrow and
Matoltsy 1974).
SigniWcant insights into the regulation of desmosomal
adhesion also came from the Weld of dermatology since it
was demonstrated that autoantibodies in patients suVering
from the autoimmune blistering skin diseases pemphigus
vulgaris (PV), and pemphigus foliaceus (PF), are directed
to Ca2+-sensitive cell surface proteins within desmosomes
(Eyre and Stanley 1987, 1988; Jones et al. 1986b; Karpati
et al. 1993), which were identiWed as the desmosomal cad-
herins desmoglein 1 (Dsg 1) and Dsg 3 (Amagai et al.
1991; Koulu et al. 1984). The term “pemphigus” comes
from the greek word “pemphix” (blister) and is being used
in dermatology since 1791 (Schmidt et al. 2000), long
before it was found that pemphigus is associated with auto-
antibodies against keratinocyte surface antigens (Beutner
and Jordon 1964) and that these antibodies are suYcient to
cause acantholysis, i.e. loss of cell–cell adhesion, in human
skin in vivo and in vitro (Anhalt et al. 1982; Schiltz and
Michel 1976). The Wnal break-through was the Wnding that
autoantibodies against the extracellular domains of Dsg 3
and Dsg 1 in PV and in PF are pathogenic (Amagai et al.
1995, 1994a, 1992). Therefore, autoantibodies from pem-
phigus patients have been used to characterize the mecha-
nisms involved in the regulation of desmosomal adhesion.
Except from pemphigus, other diseases in which desmo-
somal adhesion is altered by mutations or bacterial toxins
helped to elucidate the functional role of the diVerent des-
mosomal components.
During the last past several years, a number of compre-
hensive reviews have been published on both desmosome
structure and function (Dusek et al. 2007b; Garrod et al.
2002; Getsios et al. 2004b; Green and Simpson 2007;
Holthofer et al. 2007; Kitajima 2002; Kottke et al. 2006;
Muller et al. 2008a; Yin and Green 2004) and/or on the
mechanisms involved in pemphigus pathogenesis (Amagai
2003; Hashimoto 2003; Lanza et al. 2006; Payne et al.
2004; Sharma et al. 2007; Sitaru and Zillikens 2005;
Stanley and Amagai 2006), which indicates that the per-
spective of the existing model of the desmosome and its
role in pemphigus pathogenesis are constantly reshaped.
Moreover, because even textbook knowledge such as on the
molecular composition of myocardial intercalated discs
needs revision (Borrmann et al. 2006; Franke et al. 2006), it
becomes obvious that after almost 150 years of desmosome
research, our knowledge is still far from complete. This
article focuses on the mechanisms regulating desmosomal
adhesion, which are compromised in diseases such as
pemphigus.
The ultrastructure and composition of desmosomes
The Wrst detailed analysis of desmosome ultrastructure was
provided by Odland (1958). Desmosomes are discoid junc-
tions with a diameter of about 0.2–0.5 m and are com-
posed of two electron-dense plaques in each of the two cells
which are separated by an intercellular cleft of 24–30 nm
(Figs. 1,  2) (Farquhar and Palade 1963; Odland 1958).
Within the plaques, an outer dense plaque can be separated
from a less dense inner plaque, the latter of which is linked
to loops of intermediate Wlament bundles (Kelly 1966).
Desmosomes contain members of at least three protein
families. Desmosomal cadherins form the intercellular
adhesive interface, whereas armadillo and plakin family
proteins built up the plaques. It is believed that the cyto-
plasmic tail of Dsgs and Dscs interact with plakoglobin
which in turn binds to desmoplakin (Fig. 1). Desmoplakin
Wnally is anchored to the intermediate Wlament cytoskeleton
(Green and Simpson 2007). These interactions seem to be
stabilized laterally by plakophilin (Hatzfeld 2007).
Fig. 1 Molecular model of the desmosome. The desmosomal cadher-
ins desmoglein and desmocollin undergo homophilic and heterophilic
binding via interaction with the amino-terminal extracellular (EC) 1
domain of partner molecules on the same (cis) as well as on the neigh-
bouring cell (trans). The cytoplasmic domains are largely embedded in
the outer dense plaque (ODP) where they are associated with plakoglo-
bin and plakophilin. In the inner dense plaque (IDP), desmoplakin
links these adaptor molecules to the intermediate Wlament cytoskeletonHistochem Cell Biol (2008) 130:21–54 23
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Desmosomes and desmosome-like junctions
Adhering junctions are divided into two main forms: (1)
desmosomes, which serve as anchoring structures for inter-
mediate Wlaments to desmosomal cadherins, and (2) adher-
ens junctions, which contain cell-type speciWc adhesion
molecules from the cadherin super-family that are linked to
the actin cytoskeleton. Both, desmosomes and adherens
junctions can be found as constituents of more elaborated
cell contact complexes. Moreover, chimeric cell contacts
exist which share features of both adherens junctions and
desmosomes.
Junctional complexes
Polarized epithelial cells display junctional complexes
located at the uppermost section of the baso-lateral mem-
brane. In apico-basal direction, the complex is composed of
the zonula occludens (tight junction), the zonula adherens
and a desmosome (macula adherens) (Farquhar and Palade
1963). Accompanied by a line of separated desmosomes,
the zonula occludens and the zonula adherens span the
entire cell by forming continuous junction belts. These
junctional complexes are regarded as hallmarks of pola-
rized epithelial cells but diVer in terms of size and ultra-
structure in cell type-speciWc manner.
Area composita
The intercalated discs of the myocardium also consist of
three types of cell junctions, i.e. adherens junctions, desmo-
somes and gap junctions (Fig. 3). Although “transitional
forms” between adherens junctions and desmosomes were
described in the very beginning (Fawcett and Selby 1958),
most morphological studies regarded the intercalated discs
to be composed of separated desmosomes and adherens
junctions, the former linked to the desmin type intermediate
Wlament cytoskeleton and the latter to actin Wlaments of the
myoWbrills (Fig. 3) (Fawcett and McNutt 1969; McNutt
and Fawcett 1969; Shimada et al. 2004). This view seemed
to be supported by immuno-localization studies, which
showed that desmoplakin as a desmosomal marker and the
myocardial adherens junction protein N-cadherin displayed
mutually exclusive spatial distribution patterns (Angst et al.
1997; Gutstein et al. 2003). However, a recent comprehen-
sive set of studies unequivocally demonstrated that the des-
mosomal components desmoglein 2 (Dsg 2), desmocollin 2
(Dsc 2), desmoplakin and plakophilin-2 as well as the
adherens junction components N-cadherin, cadherin-11,
-catenin and -catenin, afadin, vinculin and ZO-1 are pres-
ent in all parts of intercalated discs irrespective of whether
their ultrastructure resembles more closely  typical desmo-
somes or adherens junctions (Borrmann et al. 2006; Franke
et al. 2006). It seems that the two types of junctions coa-
lesce within the Wrst-year postpartum and that plakophilin 2
is of special importance for junction integrity (PieperhoV
and Franke 2007; PieperhoV et al. 2008). Therefore, the
intercalated discs were now reclassiWed as “area compo-
sita”, a mixed type of adhering junctions.
Fig. 2 Ultrastructure of the desmosome. The electron micrograph of a
keratinocyte desmosome shows the desmosomal plaque with inserting
cytokeratin intermediate Wlaments as well as some fuzzy material with-
in the extracellular space likely reXecting the extracellular domains of
desmosomal cadherins
Fig. 3 Ultrastructure of the area composita of a myocardial interca-
lated disc. The electron micrograph shows an intercalated disc contain-
ing a gap junction (GJ) in its longitudinal section as well as an adhering
junction with an extensive electron-dense plaque in the section perpen-
dicular to the cellular axis. Note that insertion of actin Wlaments, which
is typical for adherens junctions, is present in some parts of the junction
(asterisk) but not in others (hash key). Based on the recent Wnding that
all parts of these adhering junctions contain the same set of desmo-
somal components, they are now deWned as area composita24 Histochem Cell Biol (2008) 130:21–54
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Complexus adhaerentes and meningeal junctions
Lymphatic endothelial cells in certain lymphatic vessels
and in the sinus of lymph nodes form a kind of chimeric
cell contact, which contains components from desmosomes
(desmoplakin, plakoglobin), adherens junctions (VE-cad-
herin, -catenin, -catenin, afadin) as well as from tight
junctions (claudin-5 and ZO-1) (Hammerling et al. 2006;
Schmelz and Franke 1993; Schmelz et al. 1994). The ultra-
structure of complexus adhaerentes shares features of both
adherens junctions and desmosomes. Complexus adhearen-
tes form continuous belt-like junctions similar to adherens
junctions of vascular endothelial cells, whereas their junc-
tional plaques are more similar to desmosomes. It was pro-
posed that plakoglobin in these contacts is responsible for
recruitment of desmoplakin (Kowalczyk et al. 1998).
Recently, in meningeoma cells, a new type of adhering
junctions was discovered in which adherens junctions also
contained the desmosomal plaque protein plakophilin 2
(Akat et al. 2008).
The desmosomal components
Desmosomal cadherins
The desmosomal members of the cadherin superfamily,
desmogleins (Dsg 1–4) and desmocollins (Dsc 1–3), are
single-pass transmembrane glycoproteins, which mediate
adhesion in Ca2+-dependent manner (Buxton et al. 1993;
Garrod et al. 2002; Getsios et al. 2004b; Nollet et al. 2000).
Desmosomal adhesion molecules have been Wrst isolated
from desmosomal intercellular regions (Gorbsky and Stein-
berg 1981). Using speciWc antibodies to localize proteins at
the cell surface and to inhibit desmosome formation, Dsc 1
(130 kDa) and Dsc 2 (115 kDa) were shown to be directly
involved in cell–cell adhesion (Cowin et al. 1984) and later
on were identiWed to be cadherin family proteins (Collins
et al. 1991; Koch et al. 1991b). Similarly, Dsg 1 (165 kDa),
Dsg 2 (116 kDa), Dsg 3 (130 kDa) and Dsc 3 (110 kDa)
were characterized (Amagai et al. 1991; Arnemann et al.
1991; Jones et al. 1986a; King et al. 1995; Koch et al.
1991a, 1990; Schafer et al. 1994; Schmelz et al. 1986a, b).
More recently, Dsg 4 (108 kDa) was found to be the princi-
pal Dsg expressed in hair follicles (Kljuic et al. 2003; Whit-
tock and Bower 2003). The genes encoding desmosomal
cadherins, which share an amino acid identity of approxi-
mately 30–50%, both with each other and with classical
cadherins, are all located on chromosome 18 in humans
(Cowley et al. 1997). Mouse models revealed that Dsg 2
and Dsc 3 are the most important desmosomal cadherin
members because deWciency caused embryonic lethality
(Table 1) (Den et al. 2006; Eshkind et al. 2002). Because
lethality induced by Dsc 3 deWciency occurred before
mature desmosmes were formed, and because Dsg 2 was
observed to be also localized outside of desmosomes in
embryonal stem cells, non-desmosmal functions of Dsc 3
and Dsg 2 seemed to be responsible in this context. In con-
trast, ablation of cadherins with more restrictive expression
patterns such as Dsc 1 led to localized superWcial epidermal
acantholysis or mucosal and deep epidermal splitting in
traumatized skin accompanied by hair loss in the case of
Dsg 3 (Chidgey et al. 2001; Koch et al. 1998). Dsg 4 muta-
tions are followed primarily by defective hair formation
(Kljuic et al. 2003).
The structure of desmosomal cadherins
Desmosomal cadherins are type I integral membrane pro-
teins. The amino-terminal extracellular domain of desmo-
somal cadherins consists of four cadherin repeats (EC1–4)
of about 110 amino acids followed by a less related mem-
brane-proximal domain (EC 5) (Dusek et al. 2007b). Based
on the crystal structure of classical cadherins (Boggon et al.
2002; Overduin et al. 1995; Shapiro et al. 1995), the EC 1–
4 domains are thought to be connected via Xexible linkers
which are rigidiWed by binding of up to three Ca2+ ions each
(Pertz et al. 1999). In the cytoplasmic domain, a juxtamem-
branuous anchor (IA) region is located which, at least in the
case of Dsc 1a, contains a desmoplakin-binding element
(Troyanovsky et al. 1994b) and maybe be involved in bind-
ing and traYcking of p120catenin similar to its role in
E-cadherin (Miranda et al. 2003). The following cadherin-
typical sequence (ICS) is required for binding to plakoglo-
bin (Mathur et al. 1994; Troyanovsky et al. 1994a). For
desmocollins, in which a long and short “a” and “b” iso-
form is generated by alternative splicing (Collins et al.
1991), it has been shown that the ICS domain is lacking in
the b isoform which therefore is unable to bind plakoglobin
but instead associates with plakophilin 3 (Bonne et al.
2003; Troyanovsky et al. 1993). The functions of the C-ter-
minal proline-rich linker (L), the Dsg-speciWc repeated unit
domains (RUDs) and the desmoglein terminal domain
(DTD), which are all only present in desmogleins, are not
clear (Dusek et al. 2007b).
The Ca2+-dependency of desmosomal cadherin-mediated 
binding
It is well established that binding of desmosomal and clas-
sical cadherins is strictly Ca2+-dependent (Chitaev and
Troyanovsky 1997; Heupel et al. 2007; Pertz et al. 1999;
Waschke et al. 2007). For Dsg 1, Ca2+-dependency of hom-
ophilic binding has been characterized in more detail. It
was found that the Ca2+ concentration for half-maximal
binding activity of Dsg 1 is 0.8 mM Ca2+ and that binding isHistochem Cell Biol (2008) 130:21–54 25
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Table 1 Desmosome-associated diseases in humans and in transgenic mouse models
Mouse model  Desmosomal component Human disease
Inactivation Genetic alteration
– Dsg 1 Striate palmoplantar keratoderma (SPPK) 
(Rickman et al. 1999)
Embryonic lethality
Defective stem cell proliferation
(Eshkind et al. 2002)
Dsg 2 Arrhythmogenic right ventricular cardiomyopathy (ARVC) 
(Pilichou et al. 2006)
Suprabasal epidermal acantholysis
Oral erosions
Hair loss
(Koch et al. 1998)
Dsg 3 –
Impaired hair keratinisation
Hyperproliferation 
(Kljuic et al. 2003)
Dsg 4 Hypotrichosis 
(Kljuic et al. 2003)
Epidermal granular layer acantholysis
Impaired barrier function
Hyperproliferation
(Chidgey et al. 2001)
Dsc 1 –
– Dsc 2 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
(Syrris et al. 2006; Heuser et al. 2006)
Embryonic lethality
(Den et al. 2006)
Dsc 3 –
Embryonic lethality
Myocardial fragility
Epidermal subcorneal acantholysis
(Bierkamp et al. 1996, 1999; Ruiz et al. 1996)
Plakoglobin Naxos disease:
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Palmoplantar keratoderma
Woolly hair
(McKoy et al. 2000)
Embryonic lethality
Defects in heart, skin, blood vessels
Neuroepithelium
(Gallicano et al. 1998, 2001)
Desmoplakin Arrhythmogenic right ventricular cardiomyopathy (ARVC)
(Rampazzo et al. 2002)
Striate palmoplantar keratoderma (SPPK)
(Armstrong et al. 1999; Whittock et al. 1999)
Carvajal syndrome:
Dilated left ventricular cardiomyopathy
Striate palmoplantar keratoderma (SPPK)
Woolly hair
(Norgett et al. 2000)
Lethal acantholytic epidermolysis bullosa:
-suprabasal epidermal blistering
-universal alopecia
-nail loss
(Jonkman et al. 2005)
– Plakophilin 1 Ectodermal dysplasia and skin fragility syndrome:
Skin blistering around mouth, on soles and palms
(McGrath 1997)
Embryonic lethality
Heart defects
(Grossmann et al. 2004)
Plakophilin 2 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
(Gerull et al. 2004)
Bacterial toxins
SuperWcial epidermal acantholysis
(Melish and Glasgow 1970; Amagai et al. 2000a, b)
Dsg 1 Staphylococcus scalded skin syndrome:
SuperWcial skin splitting
Fever, erythema
Skin tenderness
(Wrst described by Ritter von Rittershain 1878)
Autoantibodies
SuperWcial epidermal acantholysis
(Amagai et al. 1995)
Dsg 1 Pemphigus foliaceus (PF)
SuperWcial epidermal acantholysis
Pemphigus vulgaris (PV, mucocutaneous)
Suprabasal epidermal acantholysis
Mucosal erosions (mouth, larynx, nasal cavity, vagina)
(Lever 1953; Koulu et al. 1984; Amagai et al. 1991)
Suprabasal epidermal acantholysis
Mucosal erosions
(Anhalt et al. 1982; Amagai et al. 1992; Mahoney et al. 1999)
Dsg 3 Pemphigus vulgaris (PV, mucosal dominant)
Suprabasal epidermal acantholysis
(Lever 1953; Amagai et al. 1991)26 Histochem Cell Biol (2008) 130:21–54
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highly cooperative with the Hill coeYcient being ¸5 (Was-
chke et al. 2007). This indicates that Dsg 1 binding is
strong only at extracellular Ca2+concentrations higher than
0.8 mM. Although the exact extracellular Ca2+concentra-
tion within the epidermis is unknown, it has been shown
that a gradient exists with low Ca2+concentrations in the
basal layers and high concentrations in the superWcial epi-
dermis (Elias et al. 2002; Menon and Elias 1991). There-
fore, if homophilic binding of Dsg 1 occurs in vivo, it has to
be considered that it may contribute to eVective intercellu-
lar adhesion only in the superWcial epidermis.
Transinteraction mechanisms of desmosmal cadherins
At present, it is still a matter of debate how desmosmal cad-
herins interact with each other in vivo. However, several
lines of evidence indicate that the N-terminal EC 1 domain
is important. Similar to classical cadherins, desmosomal
cadherins contain a cell adhesion recognition (CAR) site
containing a central alanine residue (Blaschuk et al. 1990).
However, instead of the conserved tripeptide HAV
sequence of classical cadherins, the sequence is YAT for
Dsc 1 and RAL for Dsg 1, respectively (Tselepis et al.
1998). Peptides derived from these sequences were able to
block homophilic adhesion mediated by Dsg 1 and Dsc 1
and to inhibit desmosomal adhesion in epithelial cells when
the peptides for Dsg 1 and Dsc 1 were applied together,
indicating that the CAR site in the EC 1 domain is critical
for maintenance of desmosmal adhesion (Runswick et al.
2001; Tselepis et al. 1998). This hypothesis is supported by
studies in which mechanisms underlying the loss of kerati-
nocyte cohesion in pemphigus were investigated. AK23, a
monoclonal Dsg 3 antibody from a PV mouse model
directed against the predicted binding motif of the EC 1,
has been shown to be pathogenic in vivo whereas anti-
bodies targeting other parts of the Dsg 3 extracellular domain
were not (Tsunoda et al. 2003). Together with the recent
Wnding that AK 23 similar to Dsg 3 antibodies from PV
patients, which are known to be also primarily directed
against the N-terminal part of EC 1 (Sekiguchi et al. 2001),
is able to directly interfere with Dsg 3 binding (Heupel
et al. 2007), these data demonstrate that interaction of EC 1
is crucial for Dsg 3 binding. In addition to these functional
studies, morphologic studies sought to address the mode of
desmosomal cadherin interaction within desmosomes by
using electron tomography imaging of epidermal tissue
(Al-Amoudi et al. 2007; He et al. 2003). Based on predic-
tions from the C-cadherin crystal structure, He and col-
leagues reported that in mouse epidermis several
desmosomal cadherins form knots in which cadherins dis-
play stochastic arrangement. In these knots, desmosomal
cadherins seemed to interact via their EC 1 domains with
both molecules on the same cell in cis as well as with
molecules from opposing cells in trans (He et al. 2003). 
Al-Amoudi and co-workers reWned the technique by employ-
ing cryo-electron microscopy in human epidermis. They
conWrmed cis- and trans-interactions of the EC 1 domains,
possibly via insertion of the tryptophane 2 into the hydro-
phobic pocket of the CAR site (Al-Amoudi et al. 2007).
However, they found that cis-interactions of the EC 4–5
regions may also occur and that desmosomal cadherins
rather show periodically zipper-like arrangements similar
to classical cadherins (Boggon et al. 2002).
Homophilic and heterophilic binding 
of desmosomal cadherins
In contrast to classical cadherins from adherens junctions
which primarily bind in homophilic manner, data indicate
that desmosomal cadherins undergo both homophilic and
heterophilic transinteraction. Using EC 1–2 fragments of
Dsg 2 and Dsc 2, it was shown that homophilic binding
occurs in vitro (Syed et al. 2002). Similarly, homophilic
binding of Dsg 3 was found (Amagai et al. 1994b). When
recombinant proteins consisting of the complete extracellu-
lar domain were used for atomic force microscopy (AFM)
measurements, it was demonstrated that the unbinding
force of single homophilically transinteracting molecules
was about 37–68 pN (depending on the retrace velocity
300–6,000 nm/s) for Dsg 1 with a lifetime of 0.17 s and
about 50 pN for Dsg 3 (Heupel et al. 2007; Waschke et al.
2005, 2007), which is in the same range as observed for
other types of cadherins characterized by the same method
such as VE-cadherin, N-cadherin or LI-cadherin (Baum-
gartner et al. 2003, 2000; Wendeler et al. 2007). These data
indicate that the molecular binding properties of homo-
philic adhesion of desmosomal cadherins may be compara-
ble to other cadherins.
Heterophilic binding of Dsg 2 to Dsc 1 or Dsc 2 was
also found on the molecular level (Chitaev and Troyanov-
sky 1997; Syed et al. 2002) but no interaction of Dsg 1
with Dsg 3 (Heupel et al. 2007). Aggregation assays of
transfected cells indicated that in cells, heterophilic bind-
ing of Dsgs and Dscs might be of even greater importance
than homophilic binding to induce strong intercellular
adhesion (Kowalczyk et al. 1996; Marcozzi et al. 1998;
Runswick et al. 2001) and that adhesion is strictly depen-
dent on the ratio of the respective Dsgs and Dscs (Getsios
et al. 2004a). This view is supported by the recent Wnding
that a conditional Dsc 3-deWciency in mice induced a
severe pemphigus-like phenotype with epidermal blister-
ing (Chen et al. 2007). Because antibodies in typical pem-
phigus are usually not directed against Dsc 3 but against
Dsg 1 and Dsg 3, it has to be considered that heterophilic
binding of these three molecules is important for epider-
mal cohesion in vivo.Histochem Cell Biol (2008) 130:21–54 27
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Armadillo family proteins
From the Armadillo family, plakoglobin and plakophilins
1–3 are important components of desmosomes.
Plakoglobin
Plakoglobin (82 kDa), also termed -catenin, is the only
essential desmosomal component which is also found in
typical adherens junctions (Cowin et al. 1986; Franke et al.
1989,  1983). The gene encoding for plakoglobin was
mapped to chromosome 17 (Aberle et al. 1995). Plakoglo-
bin binds to the cytoplasmic cadherin-typical sequence of
Dsgs and Dscs via its Wrst three armadillo repeat domains
(Chitaev et al. 1998). Because the same binding site is
required for interaction of plakoglobin to -catenin, the lat-
ter is excluded from desmosomes. Similarly, although the
armadillo repeat domain of -catenin can also bind to Dsg
2, its Xanking domains inhibit this interaction, which may
explain the absence of -catenin from desmosomes (Troya-
novsky et al. 1996; Wahl et al. 1996). Plakoglobin has been
demonstrated to interact with other desmosomal plaque
components such as desmoplakin, plakophilins and also
with cytokeratin Wlaments (Bonne et al. 2003; Chen et al.
2002; Kowalczyk et al. 1997; Smith and Fuchs 1998). The
importance of this linker function can be concluded from
studies in which inactivation of plakoglobin led to embryonic
lethality due to mechanical fragility of the myocardium
and, when mice are viable, to subcorneal skin blistering
indicating that plakoglobin is essential for desmosomal
stability (Table 1) (Bierkamp et al. 1996; Ruiz et al.
1996).
Besides its function as a desmosomal adaptor protein,
plakoglobin seems to be involved in nuclear signalling. It
has been shown that plakoglobin, comparable to -catenin
in the canonical wnt signalling pathway, confers transcrip-
tional activity together with TCF-4/LEF transcription fac-
tors (Maeda et al. 2004). This mechanism seems to interfere
with  -catenin-mediated transcription (Hu et al. 2003).
Because plakoglobin like -catenin is a target of glycogen
synthase kinase-3 , which drives proteosomal degradation
of both proteins (Kodama et al. 1999; Muller et al. 2008a;
Williamson et al. 2006), a complex pattern of direct and
indirect transcriptional regulation seems likely. A target
gene of Lef-1/plakoglobin signalling is c-Myc, the expres-
sion of which was inhibited in keratinocytes but enhanced
in transformed rat kidney epithelial cells (Kolligs et al.
2000; Kolly et al. 2007; Williamson et al. 2006). This indi-
cates that the role of plakoglobin transcriptional regulation
is strictly cell type-dependent. In keratinoytes, c-Myc
repression by plakoglobin is required to stop proliferation
and to allow terminal diVerentiation (Williamson et al.
2006). Another potential target gene is the anti-apoptotic
molecule Bcl–XL, which was found to be upregulated in
plakoglobin-deWcient cells leading to reduced apoptosis
and thus might also be repressed by plakoglobin (Dusek
et al. 2007a). Taken together, plakoglobin serves as func-
tional linker between intercellular adhesion and regulation
of the cell cycle. This might also be important for cancer
progression because many tumors are characterized by loss
of plakoglobin expression.
Plakophilins
Plakophilin 1 (80 kDa) was Wrst identiWed as an “acces-
sory” plaque protein because, in contrast to plakoglobin and
desmoplakin, it was found in cells from certain stratiWed
and complex epithelia only (Franke et al. 1983; Hatzfeld
et al. 1994; Heid et al. 1994). Afterwards, it became clear
that plakophilin 2 (100 kDa) is ubiquitously present in all
desmosomes and also plakophilin 3 (87 kDa) is present in
most simple and stratiWed epithelia (Mertens et al. 1999;
Schmidt et al. 1999). The genes encoding plakophilin 1, 2
and 3 are located on chromosomes 1, 12, and 11, respec-
tively (Bonne et al. 1998). Plakophilin 1 and 2 exist in two
splice variants with a shorter “a” and a longer “b” form
(Mertens et al. 1996; Schmidt et al. 1997). In addition to
their localization in desmosomes, plakophilins 1 and 2 are
also found in the karyoplasm in a variety of cells and plako-
philin 1 b is exclusively located in the nucleus. Plakophilin
2 deWciency leads to embryonic death due to heart defects
indicating that the presence of at least one member of the
plakophilin family is required (Table 1) (Grossmann et al.
2004). Under these conditions, cytokeratin Wlaments were
retracted from cell borders and desmoplakin was localized
in the cytoplasm rather than at desmosomes in cardiomyo-
cytes, demonstrating the relevance of plakophilin 2 to des-
mosplakin recruitment. Because cardiomyocytes in contrast
to epithelial cells express only plakophilin 2 but not plako-
philin 1 and 3, defects were present in the heart only,
whereas epithelia were not aVected.
Plakophilins can directly interact with all other desmo-
somal components including cytokeratins via the aminoter-
minal head domain (Bonne et al. 2003; Hatzfeld 2007;
Hatzfeld et al. 2000). Plakophilin 1 recruits desmosomal
components to the cell membrane, increases size and num-
ber of desmosomes and therefore seems to be a scaVolding
protein, which induces desmosome assembly (Hatzfeld
et al.  2000; Kowalczyk et al. 1999; Wahl 2005). On the
other hand, because plakophilin 1 is located in the dense
inner desmosomal plaque whereas cytokeratin Wlaments
only loop into the outer plaque, it is believed that plakophi-
lin 1 enhances desmoplakin lateral interactions but does not
directly associate with cytokeratin Wlaments in vivo
(Hatzfeld 2007; North et al. 1999). It has been demonstrated
that desmosome formation is mediated by the aminoterminal28 Histochem Cell Biol (2008) 130:21–54
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domain, whereas recruitment of plakophilin 1 itself to the
plasma membrane is dependent on the carboxyterminal
region (Sobolik-Delmaire et al. 2006).
In addition to its function in the regulation of desmo-
some assembly, plakophilins may also regulate signalling
mechanisms, both at cell borders as well as in the nucleus.
Plakophilin 1 associates with actin Wlaments at cell borders
and has been reported to interact with a GTP exchange fac-
tor (GEF) for Rho and thereby could regulate activity of
Rho GTPases similar to the closely related p120-catenin,
which is known to inhibit Rho A and to activate Rac 1 and
Cdc42 (Anastasiadis and Reynolds 2001; Hatzfeld 2007).
In addition to their localization within the desmosomal
plaque, plakophilin 1 and 2 are also present inside nucleus
and plakophilin 2 has been found to be part of the polymer-
ase III complex which is responsible for generation of
tRNA and rRNA (Mertens et al. 2001). By these two mecha-
nisms, it is possible that plakophilins may regulate cell
adhesion and cell growth (Hatzfeld 2007).
Plakin family proteins
Plakin family proteins are linkers between the cytoskeleton
and cell–cell or cell–matrix contacts (JeVerson et al. 2007).
Desmoplakin, which exists in two spice variants of a pro-
tein encoded by a single gene on chromosome 6 (desmopla-
kin I: 322 kDa; desmoplakin II: 259 kDa), is an essential
component of the desmosomal plaque and therefore is
regarded as the prototype of this family (Armstrong et al.
1999; Hatsell and Cowin 2001; Mueller and Franke 1983;
Sonnenberg and Liem 2007). Other members such as plec-
tin, envoplakin and periplakin were also found in desmo-
somes, but their signiWcance for the structure and function
of desmosomes is less clear. Especially, plectin is primarily
important in hemidesmosmes, which anchor epithelia to the
extracellular matrix.
Desmoplakin consists of an aminoterminal plakin
domain, which can interact with all other desmosomal
plaque proteins such as plakoglobin and plakophilins but
also with Dsc 1a (Kowalczyk et al. 1997; Smith and Fuchs
1998; Troyanovsky et al. 1994b). The central coiled-coil
rod domain, which is important for dimerization, is fol-
lowed by the carboxyterminal tail consisting of three globu-
lar subdomains with several plakin-repeats, which serve as
linkers for diVerent intermediate Wlament types (Choi et al.
2002; Green et al. 1990; Stappenbeck and Green 1992). It
is well established that desmoplakin is the main linker pro-
tein between the desmosomal cadherin–plakoglobin com-
plex and the intermediate Wlament cytoskeleton. This has
been shown in vitro and was ultimately demonstrated in
desmoplakin-deWcient mice, which had a reduced number
of desmosomes and died at embryonic stage just after
implantation (Table 1) (Bornslaeger et al. 1996; Gallicano
et al. 1998). Similar to the Wndings in epidermal-speciWc
desmoplakin-deWcient mice, which suVered from skin blis-
tering, desmosomes were not anchored to intermediate Wla-
ments (Vasioukhin et al. 2000). Moreover, when
desmoplakin was rescued in extraembryonic tissues so that
embryos further developed, defects were present not only in
the myocardium and epidermis but also in the vasculature
and in the neuroepithelium, underlining the importance of
desmoplakin for tissue diVerentiation (Gallicano et al.
2001).
Diversity of desmosomes in diVerent tissues and speciWc 
epithelial layers
Although it was discovered about 25 years ago that the
structure of desmosomes is not identical in all types of cells
and tissues (Giudice et al. 1984; Jones et al. 1986b), the
knowledge on the diversity of desmosomes is still uncom-
plete and matter of discussion (Garrod et al. 2002; Getsios
et al. 2004b; Green and Simpson 2007; Hatzfeld 2007; Hol-
thofer et al. 2007; Kottke et al. 2006; Yin and Green 2004).
The diversity of desmosomes has implications for tissue
diVerentiation and also is of high-medical relevance
because diseases caused by genetic alteration of or by an
autoimmune reponse against a speciWc desmosomal com-
ponent may aVect only certain but not all desmosome-con-
taining tissues.
Some desmosomal components such as Dsg 2, Dsc 2 and
the plaque proteins desmoplakin, plakoglobin and plako-
philin 2 are ubiquitously expressed in all cells and tissues in
which desmosomes are found. Plakophilin 3 is present in
most simple epithelia except hepatocytes as well as in strat-
iWed epithelia, whereas plakophilin 1 is restricted to strati-
Wed and complex epithelia. In epithelia, the desmosomal
cadherins show typical expression patterns. Simple epithe-
lia and urothelium usually express Dsg 2 and Dsc 2 only.
Apparently, exceptions are the additional presence of Dsg 1
in the mucosa of uterus, stomach, intestine and in epithelia
of liver and pancreas as well as the expression of Dsc 1 in
intestine and liver or Dsc 3 in stomach, prostate, salivary
gland and urothelium. Dsg 4 has a unique tissue distribu-
tion in skin and several simple epithelia such as those pres-
ent in pancreas, salivary glands, testis, prostate and hepatic
epithelium.
The Dsg 1/Dsc 1 and Dsg 3/Dsc 3 pairs are largely con-
Wned to stratiWed epithelia where the expression patterns of
the Dsg and Dsc isoforms usually conform. Interestingly, in
the stratiWed corneal epithelium, only Dsg 1 and Dsc1 are
present indicating that these desmosomal cadherins in the
absence of Dsg 1 and Dsg 3 are suYcient to maintain cohe-
sion in stratiWed epithelia also. In the epidermis, the plaque
proteins plakoglobin, desmoplakin and plakophilin 3 are
expressed in all layers (Fig. 4). In contrast, plakophilins 1Histochem Cell Biol (2008) 130:21–54 29
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and 2 display inverse distribution with plakophilin 1 being
more abundant in the superWcial epidermis. These inverse
expression patterns are also typical for the Dsg 1/Dsc 1 and
Dsg 3/Dsc 3 pairs. Dsg 1/Dsc 1 are the predominant desmo-
somal cadherins in the superWcial epidermis, whereas Dsg
3/Dsc 3 are primarily expressed in the lower epidermis. In
contrast to Dsg 1, which can be detected in some desmo-
somes in keratinocytes of the basal layer also, Dsc 1 and
Dsg 4 are absent in the basal layer (Dusek et al. 2007b;
Mahoney et al. 2006; Spindler et al. 2007). Because Dsg 3
is expressed throughout the spinous layers (Fig. 5), the
expression patterns of Dsg 1 and Dsg 3 largely overlap in
human adult epidermis (Mahoney et al. 2006; Spindler
et al. 2007). Dsc 2 is enriched in the deep epidermis with
lower levels in the superWcial epidermis, whereas Dsg 2 is
restricted to basal and suprabasal cells but is present in very
faint amounts only (Mahoney et al. 2006) indicating that
this pair of proteins may be primarily important for cell
cohesion in simple epithelia and myocardium rather than in
complex epithelia. However, it is unclear at present which
desmosomal cadherin isoforms are capable to heretophili-
cally bind to each other and thus interpretation of these dis-
tribution patterns with respect to their relevance for
mechanical adhesion is preliminary. In multilayered squa-
mous epithelium of mucous membranes, for instance of the
oral cavity, Dsg 1 and Dsg 3 are strongly expressed
throughout all layers, whereas Dsg 4 shows strong expres-
sion in superWcial layers but is missing in the basal layer
(Mahoney et al. 2006).
It is important to note that the speciWc distribution pat-
terns of desmosomal components in stratiWed epithelia are
important for epithelial diVerentiation and function (Green
and Simpson 2007). It was shown that forced overexpres-
sion of Dsg 3 in the suprabasal epidermis led to abnormal
diVerentiation and hyperproliferation as well as perinatal
lethality due to transepidermal water loss (Elias et al. 2001;
Merritt et al. 2002). Similarly, forced suprabasal Dsg 2 and
Dsc 3 overexpression resulted in hyperproliferation and
formation of papillomas, possibly via altered -catenin/wnt
signalling (Brennan et al. 2007; Hardman et al. 2005).
Desmosome assembly and disassembly
The mechanisms participating in desmosome assembly and
disassembly have been reviewed in detail elsewhere (Gets-
ios et al. 2004b; Green and Simpson 2007; Kitajima 2002;
Fig. 4 Expression patterns of desmosomal components in the epider-
mis. The schematic drawing of the epidermis (left) indicates the basal
(BL), spinous (SL), granular (GL) and corneal (CL) layer of the epider-
mis. On the right, the expression patterns of desmosomal components
in the speciWc epidermal layers are illustrated. For instance, Dsg 1 and
Pkp 1 are most prominent in the superWcial layers, whereas expression
of Dsg 3 and Dsc 3 is strongest in the deep epidermis. Dsg desmoglein,
Dsc desmocollin, Pkp plakophilin, PG plakoglobin, DP desmoplakin
Fig. 5 Immunostaining of Dsg 1 and Dsg 3 in human epidermis. Intact
human epidermis was immunostained using monoclonal antibodies
against Dsg 1 (a) and Dsg 3 (b). A merge of both panels is shown in c.
Dsg 1 is most abundant in the superWcial epidermis but is also present
in the basal layer. Dsg 3 is expressed in the basal layer as well as
throughout the spinous layer indicating that in human epidermis the
expression patterns of these two proteins broadly overlap. Scale bar is
20 m30 Histochem Cell Biol (2008) 130:21–54
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Yin and Green 2004). For instance, extracellular Ca2+ and
protein kinase C (PKC) signalling are well known to be
involved in desmosome assembly. Ca2+  concentrations
>0.1 mM allow formation of adherens junctions and des-
mosomes (Hennings and Holbrook 1983). Desmosomal
plaques with inserted cytokeratin Wlaments became visible
as early as after 5 min after the Ca2+ switch followed by
appearance of assymetrical desmosomes after 10 min and
of symmetric desmosomes after 1 h. Increased extracellular
Ca2+ induced incorporation of desmosomal components
such as Dsgs, plakoglobin and desmoplakin into the desmo-
somal plaque (Hennings and Holbrook 1983; Pasdar et al.
1995; Pasdar and Nelson 1988, 1989). Activation of PKC is
required for translocation of desmosomal components to
the cell membrane and for desmosome assembly (Sheu
et al.  1989), but also was found to reduce desmosomal
adhesion and to increase Ca2+-dependence of desmosomes
(Kimura et al. 2007) indicating that regulation of desmo-
somal adhesion by PKC is complex.
Before desmosome assembly, adhesion zippers of
E-cadherin-containing puncta form on Wlopodial processes
of neighbouring cells, an event that requires both -catenin
and VASP-driven actin reorganization (Vasioukhin et al.
2000). Afterwards, these intermediate junctions mature to
adherens junctions and desmosomes are assembled at
regions where membranes are brought together. It appears
that Dscs initiate the formation of desmosomes. This is
based on the observations that Dsc 2 is the Wrst desmosomal
component at the cell surface followed by Dsg 2 in MDCK
cells (Burdett and Sullivan 2002) and that, in keratinocytes,
N-terminally deleted Dsc 3, which compromised desmo-
some formation was still able to bind to -catenin. There-
fore, it can be speculated that Dsc 3 could localize to pre-
existing adherens junctions to induce desmosome forma-
tion (Hanakawa et al. 2000). Desmosomal cadherins seem
to be transported in vesicles from the Golgi along micro-
tubules whereas non-membranous cytoplasmic particles con-
taining desmoplakin and plakophilin are associated with
intermediate Wlaments and move towards cell-junctions by
actin-based motility (Godsel et al. 2005; Green and Simp-
son 2007). Desmoplakin traYcking seems to be dependent
on intracellular Ca2+ levels because patients with Darier’s
disease, which results from mutations in a sarcoplasmic
reticulum Ca2+ pump show desmoplakin retention in the
cytoplasm and altered desmosome structure (Dhitavat et al.
2003; Dhitavat et al. 2004; Sakuntabhai et al. 1999).
On the cell surface, the desmosomal cadherins together
with plakoglobin and desmoplakin are suYcient to nucleate
a desmosomal plaque (Kowalczyk et al. 1997). Further
plaque enlargement and desmoglein clustering are depen-
dent on plakoglobin together with plakophilin (Bornslaeger
et al.  2001; Koeser et al. 2003). Therefore, keratinocytes
deWcient for either plakoglobin or desmoplakin display
reduced numbers of desmosomes, disturbed plaque forma-
tion and reduced anchorage of cytokeratin Wlaments (Bierk-
amp et al. 1999; Vasioukhin et al. 2001). It appears that
during desmosome assembly, Dsg3-containing clusters are
formed in the beginning, which, upon attachment to cyto-
keratin Wlaments, become integrated in desmosomes (Sato
et al. 2000). Once they are formed, desmosomes are stable
throughout the cell cycle and are not disrupted during mito-
sis, although the desmosomal components are subjected to
a signiWcant turnover with a half-life of about 30 min like it
was shown for Dsc 2a (WindoVer et al. 2002). Finally, it
has to be emphasized that a reciprocal dependence of des-
mosomes and adherens junctions seems to exist. This can
be concluded from experiments in which expression of
N-terminally deleted Dsc 3 or desmoplakin deWciency
resulted in impaired formation of both desmosomes and
adherens junctions (Hanakawa et al. 2000; Vasioukhin
et al. 2001).
Regulation of keratinocyte proliferation by desmosomal 
cadherins
Evidence is accumulating that desmosomal cadherins such
as Dsg 3 regulate keratinocyte proliferation (Muller et al.
2008a). It has been shown that autoantibodies from pem-
phigus vulgaris patients induce continuing keratinocyte
proliferation by impaired Dsg 3/plakoglobin signalling,
which Wnally leads to c-Myc overexpression (Muller et al.
2008a; Williamson et al. 2007,  2006). According to this
concept, in healthy epidermis Dsg 3 binding results in inhi-
bition of glycogen synthase kinase 3 (GSK3) via activation
of phosphatidylinositol trisphosphate kinase (PI3K) and
Akt. In consequence, GSK3 phosphorylation-dependent
degradation of plakoglobin is abolished which allows pla-
koglobin to translocate into the nucleus and to induce
growth arrest via suppression of c-Myc (Muller et al.
2008a; Williamson et al. 2006).
Desmosome-associated diseases
Several diseases have been found in which impaired des-
mosomal adhesion contributes to pathogenesis. Inactivation
of desmosomal function may be reduced by completely
diVerent mechanisms including genetic defects of desmo-
somal components, cleavage of desmosomal cadherins by
bacterial toxins and binding of autoantibodies to desmo-
gleins 1, the latter of which is the cause of the autoimmune
disease pemphigus. Although altered expression of desmo-
somal cadherins such as Dsg 2/Dsc 2 and Dsg 3/Dsc 3 have
been observed in human carcinomas such as squamous cell
carcinoma as well as gastric, colorectal and breast carcinomas,Histochem Cell Biol (2008) 130:21–54 31
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mutations are usually absent (Bazzi and Christiano 2007).
Therefore, the role of desmosomal cadherins in cancer is
unclear at present.
Genetic diseases
Mutations in desmosomal plaque components in humans
aVect the myocardium as well as the epidermis with its
appendages (Table 1). Mutations in genes for the essential
desmosomal plaque components desmoplakin and plako-
globin result in heart, skin and hair defects (Bazzi and
Christiano  2007; Green and Simpson 2007; McGrath
2005). In contrast, genetic alterations of Dsg 2, Dsc 2 and
plakophilin 2 selectively lead to heart defects because these
are the only isoforms of their protein families in the myo-
cardium. On the other hand, mutations in Dsg 1 and plako-
philin 1, which are primarily expressed in the epidermis,
cause skin defects whereas loss of Dsg 4 in hair follicles
results in hair loss.
Genetic heart defects
Interestingly, all defects of desmosomal components caus-
ing heart defects such as desmoplakin, plakoglobin, plako-
philin 2, Dsg 2 and Dsc 2 lead to the phenotype of
arrhythmogenic right ventricular cardiomyopathy (ARVC)
which is clinically characterized by right bundle block and
arrhythmia and histologically by Wbrofatty replacement of
cardiomyocytes, possibly due to impaired cell adhesion
caused by loss and alterations of desmosomes (Asimaki
et al. 2007; Gerull et al. 2004; McKoy et al. 2000; Pilichou
et al.  2006; Rampazzo et al. 2002; Syrris et al. 2006;
Heuser et al. 2006). This is in line with embryonic lethality
due to myocardial rupture in mice models deWcient in these
proteins. Therefore, the thinnest parts of the right ventricle
are the most severely aVected, but left ventricle involve-
ment also occurs (van Tintelen et al. 2007). However, Wbro-
fatty transdiVerentiation of cardiomyocytes cannot be
simply explained by impaired desmosomal adhesion, but
rather seems to be caused by altered wnt/ -catenin signal-
ling in response to nuclear translocation of plakoglobin
(Garcia-Gras et al. 2006).
Genetic defects of skin and its appendages
HaploinsuYciency of the gene encoding Dsg 1 results in
the autosomal dominant skin disease striate palmoplantar
keratoderma (SPPK), which is characterized by linearly
arranged thickening of the stratum corneum on the palms,
soles, knees, ankles and Wnger knuckles (Milingou et al.
2006; Rickman et al. 1999). However, blisters are absent
indicating that disturbed diVerentiation is the primary
mechanism underyling this entity rather than a loss of
keratinocyte adhesive function. Similarly, mutated Dsg 4
leads to autosomal recessive inherited hypotrichosis due to
defective hair follicle diVerentiation, a phenotype related to
the lanceolate hair mouse (Kljuic et al. 2003). In contrast,
ablation of plakophilin 1 results in the recessive skin-fragi-
lity ectodermal dysplasia syndrome, which in 1997 was the
Wrst genetic desmosome-associated disease to be described
(McGrath 2005). Here, both loss and alterations of desmo-
somes and lacking insertion of cytokeratin Wlaments due to
inability to recruit desmoplakin cause skin blistering
around the mouth as well as on palms and soles accompa-
nied by dystrophic hair and nails (McGrath et al. 1997;
McMillan and Shimizu 2001).
Mutations in plaque proteins with involvement 
of various tissues
Mutations in plakoglobin are the cause of Naxos disease in
which ARVC and palmoplantar keratoderma are associated
with woolly hair (McKoy et al. 2000). Interestingly, in con-
trast to plakoglobin-deWcient mice (Bierkamp et al. 1996),
acantholysis is absent indicating that some mechanical
functions of plakoglobin are maintained in these patients.
The most variable phenotypes are the consequence of
desmoplakin alterations. An autosomal recessive disorder
with dilated cardiomyopathy, keratoderma and woolly hair
called Carvajal syndrome is comparable to Naxos disease
(Norgett et al. 2000). HaploinsuYciency leads to SPPK,
whereas non-sense mutations are accompanied by skin fra-
gility leading to blisters in the face as well as on extremities
and trunk and also with wolly hair (Armstrong et al. 1999;
Whittock et al. 1999, 2002). However, the most severe dis-
order is lethal acantholytic epidermolyis bullosa, which is
caused by C-terminally truncated desmoplakin and was
fatal in a 10-day-old hair and nailless newborn due to
extensive blistering leading to transcutaneous Xuid loss
(Jonkman et al. 2005). On the ultra-structural level, desmo-
somes were reduced in desmoplakin-related SPPK similar
to SPPK caused by mutations in Dsg 1 (Wan et al. 2004),
but not in lethal acantholytic epidermolysis bullosa. How-
ever, desmosome shedding, alterations of desmosomal
plaques and impaired cytokeratin insertion were typically
associated with desmoplakin mutations (Jonkman et al.
2005; Norgett et al. 2000; Wan et al. 2004). At present, it is
unclear why diVerent mutations aVect diVerent tissues.
Infectious diseases
Staphylococcal scalded skin syndrome (SSSS), which was
Wrst described by Ritter von Rittershain in 1878, is the sys-
temic variant of epidemic pemphigus neonatorum or spo-
radic bullous impetigo and is characterized by superWcial
epidermal splitting accompanied by fever, erythema and32 Histochem Cell Biol (2008) 130:21–54
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skin tenderness (Farrell 1999; Lyell 1983; Stanley and
Amagai 2006). Most cases are caused by staphylococcal
exfoliative toxin (ET), a serine protease, which has been
shown to selectively cleave Dsg 1 between EC 3 and 4 in
conformation-dependent manner, but not Dsg 3 or E-cad-
herin (Table 1) (Amagai et al. 2000a,  2002; Hanakawa
et al. 2002; Melish and Glasgow 1970). Assuming that ET
does not cleave other superWcially expressed desmosomal
cadherins such as Dsg 4 or Dsc 1, SSSS is a good example
that extensive epidermal blistering can be induced by prote-
olytic cleavage of a single adhesion molecule. According to
its bacterial pathogenesis, SSSS can be eVectively treated
with antibiotics (Stanley and Amagai 2006).
Pemphigus
Pemphigus is an autoimmune blistering skin disease, which
is characterized by intraepidermal blistering (Lever 1953).
The two major types of pemphigus are the more severe
pemphigus vulgaris (PV), which accounts for 80–90% of
cases, and pemphigus foliaceus (PF) (Bystryn and Rudolph
2005; Schmidt et al. 2000; Stanley and Amagai 2006).
Pemphigus is a rare disease with a yearly incidence of
0.75–5 cases per million and apart from being present in
humans, is also found in horses, dogs and cats. In contrast
to other autoimmune diseases, which primarily aVect
women, pemphigus is equally distributed between both
genders, and is diagnosed mostly between the fourth and
sixth decades. In PV, there are two main forms, the muco-
sal-dominant and the mucocutaneous type. In both cases,
the disease most commonly begins with painful non-heal-
ing ulcerations not only in the mucous membranes of the
mouth, but also in the larynx, nose and vagina. Later on,
Xaccid blisters may occur on the scalp, trunk, groin and
axillae, which easily rupture, leaving sharply outlined ero-
sions and heal without scarring (Fig. 6). In contrast to PV,
PF only aVects the epidermis and because epidermal split-
ting is restricted to the superWcial epidermis, lesions appear
as crusted erosions on the upper torso, face and scalp. It has
to be mentioned that pemphigus can be induced by drugs
such as penicillamine, penicillin, captopril and -blockers
and also can occur as a paraneoplastic entity accompanying
or preceding lymphoma and lung carcinoma (Yeh et al.
2003). Moreover, in South America an endemic form of
PF, called Fogo selvagem, exists, which is thought to be
transmitted by insect vectors (Aoki et al. 2004; Diaz et al.
1989). Currently, the therapy of pemphigus is based on
immunosupression and reduction of autoantibody load.
Conventional therapy includes high-dose corticosteroids,
intravenous immune globulin and cytotoxic agents. Before
systemic corticosteroids were available, 75% of PV patients
died within a year. Second-line therapies for refractory PV
include rituximab, an antibody directed against B cell
CD20, which reduces autoantibody-producing B cells as
well as plasmapheresis to physically remove autoantibodies
(Ahmed et al. 2006; Shimanovich et al. 2008).
Histology and autoantibody proWle in pemphigus
Besides the clinical phenotype, diagnosis of pemphigus is
based on histology and the patients’ autoantibody proWle
(Bystryn and Rudolph 2005). The histologic hallmark of
pemphigus is acantholysis, i.e. loss of cell–cell adhesion
between keratinocytes. In PV, the epidermal cleavage plane
is located in the deep epidermis, usually right above the
basal layer (Fig. 7). In contrast, in PF, epidermal splitting
occurs between granular layers. Skin blisters can be
induced by rubbing on healthy-appearing epidermis, a phe-
nomenon referred to as Nikolsky sign.
Autoantibodies in pemphigus are suYcient to cause blis-
tering in human skin in vivo and in vitro (Anhalt et al.
1982; Schiltz and Michel 1976). In contrast to other auto-
immune blistering skin diseases such as bullous pemphi-
goid or epidermolysis bullosa acquisita (Sitaru and
Zillikens 2005; Yancey 2005), pemphigus antibodies do not
require the complement system or leukocytes to induce
Fig. 6 Clinical phenotype of Pemphigus vulgaris and Pemphigus foli-
aceus. Patients suVering from the mucocutaneous form of pemphigus
vulgaris (PV) usually have Xaccid blisters and erosions on the trunk (a)
accompanied by mucosal ulcerations in the mouth (b). In contrast,
Pemphigus foliaceus patients are characterized by crusted epidermal
erosions (c) whereas involvement of mucous membranes is absentHistochem Cell Biol (2008) 130:21–54 33
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blisters in vivo (Anhalt et al. 1986). It is generally accepted
that PV and PF are characterized by diVerent autoantibody
proWles, which generally correlate with disease activity
(Bystryn and Rudolph 2005; Harman et al. 2001; Ishii et al.
1997; Stanley and Amagai 2006; Stanley et al. 1984; Yeh
et al. 2003). Patients suVering from mucosal-dominant PV
usually have antibodies directed against Dsg 3 but not Dsg
1, whereas mucocutaneous PV is characterized by both Dsg
3 and Dsg 1 autoantibodies (Amagai et al. 1999; Ding et al.
1997; Jamora et al. 2003; Miyagawa et al. 1999). In con-
trast, in PF patients usually antibodies against Dsg 1 but not
Dsg 3 are detected (Amagai et al. 1999). However, it is also
known that in some cases this correlation between the clini-
cal phenotype and the autoantibody proWle was not found
(Baykal et al. 2002; Jamora et al. 2003; Yoshida et al.
2005; Zagorodniuk et al. 2005).
Over the last decade, there is a debate whether these
autoantibodies against desmosomal cadherins are patho-
genic (Amagai et al. 2006). It has been shown by passive
transfer of aYnity-puriWed Dsg antibody fractions as well
as by depletion of pathogenic activity by absorption against
desmoglein extracellular domains that Dsg 1 antibodies in
PF and the combination of Dsg 1 and Dsg 3 autoantibodies
in PV as well as in paraneoplastic pemphigus are suYcient
to induce skin blistering (Amagai et al. 1995, 1994a, 1992,
1991, 1998; Koulu et al. 1984; Mahoney et al. 1999). An
active PV mouse model in which Dsg 3-deWcient mice were
immunized with Dsg 3 before splenocytes from these ani-
mals were transferred to lymphopenic Rag-2-deWcient mice
supported the notion that Dsg 3 antibodies alone can cause
mucosal erosions (Amagai et al. 2000b). Similar in kerati-
nocyte cultures, depletion of Dsg 1-speciWc antibodies from
PF-IgG by preincubation with recombinant Dsg 1 but not
after preincubation with VE-cadherin completely abolished
keratinocyte dissociation (Waschke et al. 2005).
Pemphigus IgG were found to include a plethora of more
than 20 diVerent autoantibodies against keratinocyte anti-
gens such as antibodies against Dsg 1, Dsg 4, Dsc 1-3,
desmoplakin, plakoglobin and E-cadherin and several other
proteins not associated with cell junctions (Amagai et al.
2006; Evangelista et al. 2008; Kljuic et al. 2003; Korman
et al. 1989; Nguyen et al. 2000c). For instance, in all PF
sera as well as in 79% of mucocutaneous PV sera, autoanti-
body activities against E-cadherin were detected, most of
which were due to Dsg 1 autoantibodies cross-reacting with
E-cadherin (Evangelista et al. 2008). Some of the diVerent
autoantibodies have clearly been shown not to be patho-
genic such as the Dsg 4-cross-reacting Dsg 1 antibodies in
PF (Nagasaka et al. 2004). Therefore, similar to other auto-
immune diseases, the pathogenetic relevance of autoanti-
bodies against a speciWc protein in pemphigus has to be
challenged until it has been convincingly demonstrated
(Amagai et al. 2006). However, it has been reported that
antibodies others than those directed to desmogleins also
contribute to epidermal blistering because PV-IgG not con-
taining Dsg 1 antibodies were eVective to cause blistering
in Dsg 3-deWcient mice (Nguyen et al. 2000c). It is possible
that these antibodies include antibodies to cholinergic
receptors and to pemphaxin, which have both been detected
in 85% of PV and PF sera (Grando 2006a; Nguyen et al.
2000b). The pathogenic relevance of antibodies against
cholinergic receptors was concluded from experiments
where preincubation of monkey oesophagus with PV-IgG
blocked staining by a rabbit acetylcholine receptor antibody
and the fact that this antibody induced keratinocyte dissoci-
ation in culture (Nguyen et al. 2000a). However, antibodies
against pemphaxin alone were not suYcient to induce skin
blistering (Nguyen et al. 2000b). Moreover, it has not been
demonstrated so far that autoantibodies from pemphigus
patients, which target cholinergic receptors are capable to
induce acantholysis. Therefore, at present it is safe to
believe that epidermal blistering in pemphigus is primarily
caused by antibodies against Dsg 1 and Dsg 3. These patho-
genic antibodies in PV and PF mainly belong to the IgG 4
and IgG 1 subclasses (Bhol et al. 1995; Rock et al. 1989;
Spaeth et al. 2001).
The knowledge that autoantibodies against desmosomal
cadherins are suYcient to induce acantholysis in comple-
ment- and leukocyte-independent manner makes pemphi-
gus one of the best-characterized models to study the direct
mechanisms underlying autoimmune diseases. Besides the
role of autoantibodies, the contribution of Dsg 3 autoreac-
tive T helper (Th) cells has also been characterized for PV
and endemic PF (Hertl et al. 2006). Th1 and Th2 cells in
PV recognize the extracellular domain of Dsg 3 when pre-
sented on the HLA class II alleles HLA-DR1*0402 and
HLA-DQ1*0503, whereas in Fogo selvagem patients
HLA-DR1*0402 and HLA-DR1*0101 were most com-
mon. In PV patients as well as in healthy carriers of the PV-
associated HLA II alleles, Dsg 3 and Dsg 1-autoreactive T
cells were found. In healthy individuals, Th1 cells with
Fig. 7 Typical histology of epidermal lesions from pemphigus pa-
tients. Hematoxylin eosin-stained paraYn sections from PV (a) and PF
(b) patients showed suprabasal epidermal cleavage in the PV and
superWcial granular blistering in PF. Scale bar is 50 m34 Histochem Cell Biol (2008) 130:21–54
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characteristics of regulatory T (Tr1) cells which inhibit T
cell activation were most prevalent. In contrast, in PV
patients the levels of Tr1 cells were reduced while Th2 cells
were increased (Veldman et al. 2004). Therefore, it is pos-
sible that an imbalance of autoreactive Tr1 and Th 2 cells
plays a role in the induction of PV by promoting the proli-
feration of anti-Dsg 3 producing B cells.
The mechanisms underlying pemphigus skin blistering
As a Wrst concept it was proposed that proteolytic cleavage
of molecules responsible for intercellular adhesion was the
mechanism underlying pemphigus skin blistering. Later on,
with the identiWcation of desmosomal cadherins as the tar-
get antigens of pemphigus autoantibodies and with more
sophisticated cell biologic tools at hand, the ideas of direct
antibody-mediated inhibition and of indirect signalling-
mediated reduction of desmoglein binding were developed
(Fig. 8).
Proteolytic cleavage of desmosomal cadherins
Proteolytic cleavage of cell adhesion molecules has Wrst
been suggested to be involved in pemphigus acantholysis
because protease inhibitors blocked pemphigus IgG-
induced cell detachment in culture (Farb et al. 1978). More-
over, plasminogen activator activity and expression of the
urokinase-type plasminogen activator receptor (uPAR) sys-
tem were found to be increased following treatment with
PV- and PF-IgG/serum in keratinocytes in vitro as well as
in PV patients’ skin (Feliciani et al. 2003; Hashimoto et al.
1983; Lo Muzio et al. 2002; Schaefer et al. 1996; Seishima
et al. 1997; Yamamoto et al. 2007b), possibly via phospho-
lipase C (PLC)-mediated signalling (Esaki et al. 1995).
Anti-uPA antibodies and a PA inhibitor were suYcient to
block acantholysis induced by PV- or PF-IgG in several
studies (Feliciani et al. 2003; Hashimoto et al. 1983; Mori-
oka et al. 1987) but not in that by Schuh et al. (2003). How-
ever, a deWnitive evaluation of the uPAR system for
pemphigus acantholysis became possible since a study
using uPA- and tissue PA-deWcient mice showed extensive
skin blistering in response to PV- and PF-IgG (Mahoney
et al. 1999). Thus, the plasminogen activator system does
not appear to be essential for pemphigus skin blistering but
may aggravate the phenotype, especially when secondary
inXammatory mediators such as IL-1 and TNF- are
released (Feliciani et al. 2000, 2003).
The same may hold true for other proteases such as
matrix metalloproteinases (MMP) or proteases of the
ADAM (a disintegrin and metalloproteinase) family.
MMP-9, which was overexpressed but not activated follow-
ing treatment with PV serum was reported to speciWcally
cleave Dsg 3 during apoptosis (Cirillo et al. 2007a,  d).
ADAM17 on the other hand, was upregulated by activation
of the epidermal growth factor receptor (EGFR) and caused
shedding of Dsg 2 (Bech-Serra et al. 2006; Santiago-Josefat
et al. 2007). These results may be important for PV because
EGFR activation was observed following treatment with
PV-IgG (Chernyavsky et al. 2007a; Frusic-Zlotkin et al.
2006). The presence of proteolytic enzymes in PV sera may
also explain why IgG-depleted PV sera were found to be
pathogenic in culture (Cirillo et al. 2007c). However,
because no direct evidence was provided that MMP-9 or
ADAM17 or any other proteinase cleaves members of the
Dsg family in pemphigus, the signiWcance of these Wndings
for acantholysis in pemphigus is unclear and the speciWc
proteolysis hypothesis proposed for pemphigus requires
further experimental substantiation (Cirillo et al. 2008).
Nevertheless, the fact that speciWc cleavage of Dsg 1 by
staphylococcal exfoliative toxin in bullous impetigo is
suYcient to cause a histologic phenotype comparable to PF
(Amagai et al. 2000a; Hanakawa et al. 2002) indicates that,
in principle, speciWc proteolysis could be an eVective mech-
anism in pemphigus.
Direct inhibition of desmoglein binding
Since it was discovered that autoantibodies in pemphigus
are directed to desmosomal adhesion molecules, it was
believed that these autoantibodies might directly interfere
with desmoglein binding (Fig. 8) (Amagai et al. 1991;
Jones et al. 1986a; Koulu et al. 1984), a mechanism also
refered to as “steric hindrance”(Sharma et al. 2007). This
model is attractive because it has been shown that autoanti-
bodies against Dsg 3 and Dsg 1 in PV and PF patients pri-
marily target the aminoterminal part of the EC 1 domain
(Futei et al. 2000; Hacker-Foegen et al. 2003; Ishii et al.
2008; Muller et al. 2008b; Sekiguchi et al. 2001). The EC 1
domain, according to morphologic studies on desmoglein
Fig. 8 The two principal mechanisms underlying pemphigus skin
blistering. Two principal mechanisms have been proposed by which
autoantibodies speciWc for Dsg 1 and Dsg 3 could impair desmosomal
adhesion. First, antibodies could directly interfere with desmoglein
transinteraction (a). Second, antibody binding has been shown to trig-
ger intracellular signalling pathways, which indirectly results in loss of
desmoglein-mediated binding (b)Histochem Cell Biol (2008) 130:21–54 35
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transinteraction in desmosomes, is increasingly recognized
as the part of the desmosomal cadherin ectodomain, respon-
sible for trans-interaction (Al-Amoudi et al. 2007; He et al.
2003) and may harbour the putative transadhesive interface,
based on data from the crystal structure of classical cadher-
ins (Boggon et al. 2002; Overduin et al. 1995; Shapiro et al.
1995). Moreover, it seems that autoantibody reactivity to
the aminoterminal parts (EC 1) of the Dsg 3 ectodomain
correlates with high disease activity as well as epidermal or
mucosal involvement in PV although the titers of these
antibodies do not show this correlation (Amagai et al. 1992;
Muller et al. 2006, 2008b; Salato et al. 2005).
First functional data that anti-Dsg 3 antibodies in PV
may directly interfere with Dsg 3 binding were provided
using monoclonal antibodies derived from the active PV
mouse model (Amagai et al. 2000b). AK 23, which was
directed against the aminoterminal part of EC 1 was found
to be pathogenic and capable to induce epidermal blistering
in vivo, at least when PF-IgG or exfoliative toxin A was
added to inactivate Dsg 1 (Shimizu et al. 2005; Tsunoda
et al. 2003). Antibodies to other parts of the Dsg 3 extra-
cellular domain such as AK 9 and AK 18 were ineVective to
induce blisters. Recently, by using single-molecule atomic
force microscopy (AFM), it was shown that PV-IgG as well
as AK 23 directly interfered with homophilic Dsg 3 binding
under cell free conditions (Heupel et al. 2007) which sup-
ports the hypothesis of direct inhibition of Dsg 3 binding in
PV (Stanley and Amagai 2006). However, no direct inhibi-
tion of Dsg 1 binding by PV-IgG and PF-IgG was detected
by AFM. These autoantibodies induced keratinocyte disso-
ciation and reduced binding of both Dsg 3- and Dsg 1-
coated microbeads to the surface of cultured keratinocytes,
as revealed by laser trapping (Heupel et al. 2007; Waschke
et al. 2005). These data suggest that autoantobodies inter-
fere with Dsg 1 binding rather by indirect, cell-dependent
mechanisms.
Finally, it has to be noted that, if direct inhibition occurs,
it is not possible to discriminate at present whether interfer-
ence with Dsg 3 binding in PV was mediated by steric hin-
drance, i.e. by blocking trans-interaction of desmoglein
molecules by the bound autoantibody, or rather by alloste-
ric eVects, i.e. autoantibody-induced conformational
changes of the Dsg 3 ectodomain, which in turn interfere
with Dsg 3 transinteraction. An antibody directed against
the putative transadhesive interface may directly induce
steric hindrance, whereas antibodies directed against other
parts of the desmoglein ectodomain could indirectly inhibit
desmoglein binding by allosteric mechanisms. The fact that
AK 18 and AK 9, which were directed to the middle and
the carboxyterminal parts of the Dsg 3 ectodomain, were
not pathogenic and did not directly interfere with Dsg 3
binding suggests that these speciWc antibodies were not
capable of causing allosteric hindrance (Heupel et al. 2007;
Tsunoda et al. 2003). On the other hand, an antibody
directed against the EC2 domain, although this part of the
molecule may not be involved in transinteraction, might
be large enough to cause steric hindrance of Dsg 3 tran-
sinteraction. Therefore, “direct inhibition”, instead of
“steric hindrance” of desmoglein binding should be used
until discrimination between steric and allosteric eVects is
possible.
Desmoglein compensation in pemphigus
The desmoglein compensation hypothesis was proposed to
explain the diVerent clinical phenotypes of PV and PF on
the basis of their diVerent autoantibody proWles (Amagai
2003; Payne et al. 2004; Sharma et al. 2007; Shirakata et al.
1998; Stanley and Amagai 2006; Udey and Stanley 1999).
According to this concept, in the deep epidermis which
contains both Dsg 1 and Dsg 3, Dsg 3 compensates for the
functional loss of Dsg 1 induced by Dsg 1-speciWc autoanti-
bodies, resulting in more superWcial blistering in PF
(Fig. 9). In PV, when only Dsg 3 antibodies are present, no
epidermal blistering would occur because Dsg 1 is consid-
ered to compensate for autoantibody-induced loss of Dsg 3
binding. However, acantholysis occurs in mucous mem-
branes where Dsg 3 is assumed to be the predominantly
expressed Dsg isoform, leading to the phenotype of muco-
sal-dominant PV. When autoantibodies to Dsg 1 are also
produced in PV, epidermal blistering occurs. However, it is
unclear why the cleavage plane is restricted to the deep epi-
dermis in PV since in PF Dsg 1 autoantibodies cause super-
Wcial blistering (Fig. 10). For this reason and other reasons
such as the cases of pemphigus in which the autoantibody
proWles do not correlate with the clinical phenotype or the
presence of other desmosomal cadherin isoforms in the epi-
dermis, this concept has been challenged (Amagai et al.
2006; Bystryn and Rudolph 2005; Muller et al. 2002; Spin-
dler et al. 2007).
Experimental support for the desmoglein compensation
hypothesis in vivo was obtained in mice. It was shown that
PF-IgG were suYcient to cause skin blistering in Dsg 3-
deWcient mice but not in normal mice (Mahoney et al.
1999). In skin layers where Dsg 1 and Dsg 3 were found,
autoantibodies against both desmogleins were required for
blistering. In line with these Wndings, forced expression of
Dsg 3 in the superWcial epidermis abolished the ability of
PF-IgG to induce acantholysis in mice (Wu et al. 2000). In
contrast, in human skin and in cultured human keratino-
cytes in vitro, PF-IgG were eVective to induce acantholysis
despite of the presence of both Dsg 1 and Dsg 3 (Spindler
et al.  2007). The discrepancy between these conXicting
Wndings may be explained in part by the notion that the
desmoglein compensation hypothesis is based on the fol-
lowing two assumptions: (1) the expression pattern of Dsg36 Histochem Cell Biol (2008) 130:21–54
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3 and Dsg 1 do not substantially overlap in epidermal and
mucosal layers where the cleavage plane in PV and PF is
located. (2) Dsg 1- and Dsg 3-speciWc autoantibodies only
lead to inactivation of either Dsg 1 or Dsg 3, respectively.
Because of the latter, the desmoglein compensation hypo-
thesis has been used to promote the idea that autoantibodies
reduce Dsg binding by direct inhibition rather than by
unspeciWc proteolysis (Mahoney et al. 1999).
Regarding the distribution of Dsg 1 and Dsg 3, it is
important to note that Dsg 3 expression patterns in speciWc
epidermal layers are diVerent in mice and men. In mice,
expression of Dsg 3 is restricted to the basal and immedi-
ately suprabasal epidermal layer (Mahoney et al. 2006,
1999). In human skin, when PV and PF were used for stain-
ing, a similar staining pattern was revealed (Amagai et al.
1996; Shimizu et al. 1995). In contrast, when speciWc anti-
bodies or in situ hybridisation were used for Dsg 3 mapping
in human epidermis, it was demonstrated that Dsg 3 is pres-
ent throughout the spinous layers and thus Dsg 3 distribu-
tion showed substantial overlap with expression of Dsg 1
(Arnemann et al. 1993; Mahoney et al. 2006; Spindler et al.
2007). However, immunostaining of human epidermis
using another monoclonal antibody detected expression of
Dsg 3 in the lower epidermis only (Wu et al. 2000). In oral
mucosa, equally strong expression of Dsg 1 and Dsg 3 was
found throughout the epithelium when speciWc antibodies
were used (Mahoney et al. 2006), whereas Dsg 1 staining
intensity was found to be much lower when PV-IgG were
used for immunstaining (Shirakata et al. 1998). Taken
together, the expression patterns of Dsg 1 and Dsg 3
broadly overlap in human epidermis and appear to be iden-
tical in oral mucosa.
With respect to the second assumption the desmoglein
compensation is based on, i.e. selective inactivation of Dsg 1
but not of Dsg 3 by Dsg 1-speciWc antibodies, it was
shown recently that both PF-IgG (only containing Dsg 1-
speciWc antibodies) and PV-IgG from patients with only
Dsg 3-speciWc antibodies were equally eVective to reduce
binding of Dsg 1- and Dsg 3-coated beads to the surface of
cultured keratinocytes (Heupel et al. 2007; Spindler et al.
2007). These data indicate that PV-IgG and PF-IgG can
reduce binding of Dsg 1 and Dsg 3, at least on the keratino-
cyte cell surface. Taken together, the relevance of desmog-
lein compensation for pemphigus pathogenesis in humans
cannot be concluded from experiments in mice, especially
because distribution patterns of Dsg 1 and Dsg 3 substan-
tially diVer in the two species. Therefore, alternative mod-
els have to be worked out to explain the diVerent epidermal
Fig. 9 The desmoglein compensation hypothesis. Based on the diVer-
ent autoantibody proWles in PV and PF together with the Wndings that
Dsg 3 is present in the deep epidermis only whereas Dsg 1 is primarily
expressed in the superWcial epidermis, the desmoglein compensation
hypothesis has been proposed to explain the epidermal cleavage planes
typical for PV and PF. According to this model, blistering in PF aVects
the superWcial epidermis because Dsg 3 is present in the deep epider-
mis to compensate for the autoantibody-induced loss of Dsg 1 binding.
In PV, epidermal involvement would occur only when autoantibodies
against both Dsg 1 and Dsg 3 are present because Dsg 1 is found in all
epidermal layers and could compensate for loss of Dsg 3 binding when
antibodies to Dsg 3 are solely presentHistochem Cell Biol (2008) 130:21–54 37
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cleavage planes in PV and PF. These may involve diVerent
signalling pathways required for maintenance of desmo-
somal adhesion in the speciWc epidermal layers as outlined
below.
Signalling pathways in pemphigus and in desmosome 
disassembly
Since it has been shown that PV-IgG upon binding to kerat-
inocytes induced a rapid transient increase of intracellular
Ca2+ (Seishima et al. 1995), several signalling pathways
have been shown to be involved in pemphigus pathogenesis
(Fig. 8) (Kitajima 2002; Lanza et al. 2006; Sharma et al.
2007; Sitaru and Zillikens 2005). Interestingly, evidence
has been provided that transadhering non-desmosomal cad-
herins, for instance Dsg 3, are involved in “outside-in” sig-
nalling and that binding of pemphigus IgG interferes with
this function (Muller et al. 2008a). This can be concluded
from experiments which showed that autoantibody binding
as well as keratinocyte separation started between desmo-
somes (Sato et al. 2000; Takahashi et al. 1985) and that
non-junctional Dsg 3 and plakoglobin were depleted Wrst
before changes in the desmosomal fractions were present
(Aoyama and Kitajima 1999; Williamson et al. 2006;
Yamamoto et al. 2007a). Interestingly, to trigger Dsg-
induced signalling, autoantibody-mediated cross-linking of
Dsg 3 and Dsg 1 seems not to be required because monova-
lent Fab fragments and single-chain variants of PV- and
PF-IgG were eVective to cause skin blistering in vivo and to
disrupt the desmosomal plaque in vitro (de Bruin et al.
2007; Ishii et al. 2008; Payne et al. 2005; Rock et al. 1990).
Ca2+, PLC and PKC It was shown that PV-IgG caused a
rapid, transient phospholipase C (PLC)-dependent increase
of inositol 1,4,5 trisphosphate and of intracellular Ca2+
leading to activation of both PKC and plasminogen activa-
tor (PA) (Esaki et al. 1995; Kitajima et al. 1999; Memar
et al. 1996; Osada et al. 1997; Seishima et al. 1995, 1999).
Because a chelator of intracellular free Ca2+ blocked kerati-
nocyte dissociation in vitro and inhibitors of calmodulin,
PLC and PKC were eVective to block PV-IgG-induced
acantholysis in vivo (Arredondo et al. 2005; Sanchez-Car-
pintero et al. 2004), it is possible that this signalling path-
way may be involved in PV acantholysis. However,
because the PA system is not believed to be crucial in this
process, PKC signalling may contribute to PV acantholysis
Fig. 10 Immunostaining of Dsg 1 and Dsg 3 in PV lesional epidermis.
Epidermis from a patient with mucocutaneous PV was stained for Dsg
1 (a) and Dsg 3 (b). A merge of both panels is shown in c. Both Dsg 1
and Dsg 3 are expressed in the basal layer underneath the blister as well
as in keratinocytes in the blister roof. However, Dsg 3 staining appears
to be fragmented throughout the epidermis whereas Dsg 1 staining is
more continuous. Note that in the level of the cleavage plane the apical
membrane of basal cells shows strong immunostaining for Dsg 1 and
Dsg 3 (arrows). Therefore, based on the desmoglein compensation
hypothesis the expression patterns of Dsg 1 and Dsg 3 cannot explain
why the cleavage plane is located suprabasally in PV but not in other
epidermal layers. Scale bar is 20 m
38 Histochem Cell Biol (2008) 130:21–54
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by other pathways such as phosphorylation of -catenin in
adherens junctions (Chernyavsky et al. 2007b). This
hypothesis is supported by experiments, which showed that
keratinocyte adhesion was negatively regulated by pharma-
cologic PKC activation (Kimura et al. 2007).
p38MAPK Activation of p38MAPK at present is the most
promising signalling mechanism to be responsible for acan-
tholysis in pemphigus. It has been demonstrated in vivo
that p38MAPK and one of its downstream targets, heat
shock protein (HSP) 25, were phosphorylated in response
to PV-IgG and PF-IgG and that pharmacologic inhibition of
p38MAPK abolished blister formation (Berkowitz et al.
2006, 2007b). Similarly, p38MAPK and the human homo-
log HSP 27 were found to be phosphorylated in skin lesions
of PV and PF patients (Berkowitz et al. 2007a). In cultured
human keratinocytes, phosphorylation of p38MAPK and
HSP27 occured after 30 min of exposure to PV-IgG
(Berkowitz et al. 2005; Kawasaki et al. 2006). However,
another study found that activity of p38MAPK was not
increased before 120 min and that activity peaked after
240 min of PV-IgG treatment (Chernyavsky et al. 2007a).
In the latter study it was shown that activation was medi-
ated, at least in part, by Dsg 1- and/or Dsg 3-speciWc anti-
bodies because Dsg depletion by siRNA reduced
p38MAPK activation by 50%. Inhibition of p38MAPK
blocked autoantibody-induced keratinocyte dissociation,
Rho A inactivation, cytokeratin retraction and reorganiza-
tion of the actin cytoskeleton (Berkowitz et al. 2005; Cher-
nyavsky et al. 2007a; Waschke et al. 2006). These results
demonstrate that p38MAPK is involved in the mechanisms
leading to acantholysis and that inhibition of p38MAPK
could be a beneWcial approach to treat pemphigus patients.
Nevertheless, based on the Wnding that activation of
p38MAPK can also be a consequence of cell detachment in
rat intestinal epithelium (Rosen et al. 2002), it was pro-
posed that p38MAPK activation is a consequence of cell
dissociation (Sharma et al. 2007). However, this is unlikely
because signiWcant pemphigus-IgG-induced acantholysis
usually takes 12–24 h to occur (Berkowitz et al. 2006; Cal-
delari et al. 2001; Lanza et al. 2008; Mahoney et al. 1999;
Nagasaka et al. 2004; Nguyen et al. 2000c; Shu et al. 2007;
Spindler et al. 2007; Takahashi et al. 1985; Tsunoda et al.
2003; Waschke et al. 2005; Waschke et al. 2006; William-
son et al. 2006).
The mechanisms by which p38MAPK and HSP27 lead
to keratinocyte dissociation are largely unclear but may
involve reorganization of the keratinocyte cytoskeleton. It
has been shown recently that serine phosphorylation of
cytokeratin 8 by p38MAPK induced cytokeratin network
disassembly (Woll et al. 2007). Similarly, HSP27 was
found to associate with cytokeratin Wlaments and to inhibit
assembly of glial Wbrillary acidic protein (GFAP) (Perng
et al. 1999). Similarly, HSP25 was found to interact with
actin Wlaments and to prevent formation of aggregates of
thermally denatured actin (Panasenko et al. 2003). How-
ever, because p38MAPK-mediated phosphorylation of
HSP27 or HSP 25 promoted actin assembly and stabilized
F-actin against depolymerization in response to cytochala-
sin D or heat shock (Benndorf et al. 1994; Geum et al.
2002; Guay et al. 1997), one would expect that PV-IgG-
induced HSP27 phosphorylation also would stabilize actin
Wlaments. Therefore, it is more likely that HSP27 is part of
a salvage pathway in response to PV-IgG and does not
directly contribute to PV-IgG-induced actin reorganization.
Rho A GTPase Rho GTPases are important regulators of
the cytoskeleton and of cell adhesion (Braga and Yap 2005;
Bustelo et al. 2007; Fukata et al. 1999; JaVe and Hall
2005). In the epidermis, Rac 1 was found not to be crucial
for maintaining epithelial integrity but for stem cell diVer-
entiation, presumably via negative regulation of c-Myc
expression (Benitah et al. 2005; Chrostek et al. 2006).
Recently, it has been shown that PV- and PF-IgG-induced
epidermal splitting, keratinocyte dissociation, as well as
loss of Dsg 1 and Dsg 3 binding in vitro were accompanied
by p38MAPK-dependent inactivation of Rho A and that
speciWc activation of Rho A by the bacterial toxin cytotoxic
necrotizing factor y (CNFy) abolished these eVects (Spin-
dler et al. 2007; Waschke et al. 2006). Moreover, toxin-
mediated inactivation of Rho A and Rac 1 resulted in epi-
dermal splitting, keratinocyte dissociation and actin reorga-
nization similar to treatment with pemphigus IgG.
Especially, inactivation of Rho GTPases by toxin B caused
deep epidermal acantholysis comparable to the eVects of
PV-IgG. Based on this observation, it is tempting to specu-
late that the cleavage plane in pemphigus may in part be
explained by diVerent, layer-speciWc signalling pathways
important for keratinocyte cohesion.
Because cytokeratin retraction and actin reorganization
in response to pemphigus IgG were also abrogated by acti-
vation of Rho A, these results suggested that Rho A could
be involved in the regulation of desmoglein cytoskeletal
anchorage (Waschke et al. 2006). This idea was supported
by Triton extraction experiments which showed that Rho A
activation reduced Dsg 3 in the non-cytoskeleton bound
fraction. Alternatively, Rho GTPases may regulate endo-
cytosis of desmosomal cadherins similar to their role in
E-cadherin turnover (Akhtar and Hotchin 2001; Izumi et al.
2004; Kamei et al. 1999). Interestingly, endocytosis and
depletion of Dsg3 are increasingly recognized to contribute
to pemphigus acantholysis (Calkins et al. 2006; Yamamoto
et al.  2007a). Taken together, Rho GTPases seem to be
important for maintenance of desmosomes and activation
of Rho A could be used to develop new strategies in pem-
phigus treatment.Histochem Cell Biol (2008) 130:21–54 39
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These data are in contrast to previous Wndings, which
suggested that Rho GTPases are not involved in the regula-
tion of desmosomal adhesion. This was concluded from
experiments in keratinocytes which showed that Rac 1
inactivation by transfection with a dominant-inactive
mutant as well as inactivation of Rho A by C3 toxin for 25
min was suYcient to displace E-cadherin but not desmopla-
kin from cell junctions (Braga et al. 1997). These studies
led to the hypothesis that Rho GTPases are important regu-
lators of keratinocyte adherens junctions but not desmo-
somes (Braga and Yap 2005). However, because
inactivation of Rho A by a cell-permeable C3 fusion toxin
was suYcient to displace Dsg 3 from cell borders after
180 min, the negative results from the early study might be
caused by the shorter incubation period (Waschke et al.
2006).
Plakoglobin Besides its involvement in PV pathogenesis,
plakoglobin is important for several aspects of desmosomal
adhesion. Plakoglobin deWciency resulted in subcorneal
acantholysis, loss of desmosomes, and impaired cytoskele-
tal anchorage of desmoplakin and desmogleins in vivo and
in vitro, supporting the notion that plakoglobin is an impor-
tant cytoskeletal linker and is crucial for desmosome
assembly (Bierkamp et al. 1999; Yin et al. 2005). However,
at least in part, plakoglobin functions seem to be compen-
sated by other desmosomal plaque proteins such as plako-
philin 1 because a plakoglobin-deWcient keratinocyte cell
line displayed Dsg 3 cytoskeletal anchorage and keratino-
cyte aggregation similar to wild-type cells (Caldelari et al.
2001). The linker function of plakoglobin seems to be regu-
lated by tyrosine phosphorylation of plakoglobin because
following EGFR activation, phosphorylated plakoglobin
remained associated with Dsg 2 but not with desmoplakin
(Gaudry et al. 2001). Moreover, plakoglobin phosphoryla-
tion was shown to be required for EGFR-induced loss of
cell adhesion and to regulate binding of plakoglobin to des-
moplakin (Miravet et al. 2003; Yin et al. 2005). These data
indicate that plakoglobin is required to integrate the eVects
from extracellular cues and from diVerent signalling path-
ways in order to allow coordinated modulation of desmo-
somal adhesion. In addition, plakoglobin regulates the  turn
over of desmosomal components because the protein levels
of desmogleins as well as of plakoglobin and desmoplakin
were decreased in plakoglobin-deWcient cells (Yin et al.
2005).
With respect to pemphigus, it has been shown that
plakoglobin is critical for PV pathogenesis because kerati-
nocytes from plakoglobin-deWcient mice were resistant to
PV-IgG-induced keratinocyte dissociation, cytokeratin retrac-
tion and disruption of the desmosomal plaque (Caldelari
et al. 2001; de Bruin et al. 2007). These studies provided
Wrst evidence that direct inhibition of Dsg binding alone
cannot account for acantholysis in PV and raised the
hypothesis that plakoglobin could be part of a receptor
complex required to transfer the signal from autoantibody-
bound Dsg 3 into the cell, a phenomenon referred to as
“outside-in” signalling (Muller et al. 2008a). As outlined
above, it has been shown that plakoglobin is involved in
c-Myc repression, which is required for keratinocyte diVer-
entiation and that PV-IgG by depleting noncytokeratin-
anchored plakoglobin on the cell surface also led to c-Myc
overexpression (Williamson et al. 2006). However, as dis-
cussed below, the role of c-Myc signalling in acantholysis
is unclear at present.
EGFR The involvement of the EGFR in PV pathogenesis
has been reported by showing that EGFR activity increased
after 30 min and peaked after 60 min of PV-IgG incubation.
This was followed by activation of ERK1/2, c-Jun phos-
phorylation and Wnally by keratinocyte apoptosis (Cher-
nyavsky et al. 2007a; Frusic-Zlotkin et al. 2006). Inhibition
of EGFR reduced EGFR signalling as well as apoptosis and
acantholysis (Frusic-Zlotkin et al. 2006). This Wnding was
surprising because EGFR signalling usually is considered
to promote cell survival and proliferation (Bazley and Gul-
lick  2005; Muller et al. 2008a). However, because 60 h
were required to induce acantholysis, very high concentra-
tions of IgG (5 mg/ml) were used and activation of
p38MAPK was not detected in this study, the signiWcance
of these results is unclear.
EGFR could contribute to PV pathogenesis by stimu-
lating desmosome disassembly. It has been shown that EGF-
induced loss of keratinocyte aggregation was mediated by
plakoglobin phosphorylation, which led to uncoupling of
the desmoglein 2-plakoglobin complex from desmoplakin
and thus from the cytoskeleton (Gaudry et al. 2001; Yin
et al. 2005). Moreover, EGFR seems to negatively regulate
the protein levels of desmosomal cadherins, in part by pro-
moting their metalloproteinase-mediated degradation, as
well as the incorporation of desmosomal cadherins into the
desmosomal plaque (Bech-Serra et al. 2006; Lorch et al.
2004; Santiago-Josefat et al. 2007).
Src The tyrosine kinase Src is activated by PV-IgG within
30 min and seems to contribute to EGFR and p38MAPK
activation because inhibition of Src reduced EGFR and
p38MAPK phosphorylation by 45 and 30%, respectively
(Chernyavsky et al. 2007a). Because Src inhibition reduced
PV-IgG-induced loss of keratinocyte cohesion, cytokeratin
retraction and apoptosis in vitro and inhition of tyrosin
kinases blocked PV-IgG-induced acantholysis in vivo
(Chernyavsky et al. 2007a; Sanchez-Carpintero et al.
2004), these results indicate that Src is signiWcantly
involved in PV acantholysis. Besides activation of
p38MAPK and EGFR, a recent study provided another40 Histochem Cell Biol (2008) 130:21–54
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possible underlying mechanism: Src was shown to directly
phosphorylate p120catenin in response to PV-IgG, which
correlated with the degree of acantholysis (Chernyavsky
et al. 2007b). Because p120catenin is involved in stabiliza-
tion of classical cadherins such as E-cadherin on the cell
surface as well as in cadherin-dependent regulation of Rho
A and Rac 1 activity (Alema and Salvatore 2007; Kow-
alczyk and Reynolds 2004), Src-mediated phosphorylation
of p120catenin may be important for PV pathogenesis.
Cholinergic receptors The cholinergic system of the
human epidermis involves two classes of cholinergig recep-
tors, the nicotinic and the muscarinic acetylcholine recep-
tors (nAChR and mAChR), which in keratinocytes are
involved in the regulation of cell–cell and cell–matrix adhe-
sion as well as in cell migration (Grando 2006a). As out-
lined above, it is unclear whether autoantibodies against
cholinergic receptors in pemphigus directly contribute to
acantholysis. However, it was shown that cholinergic ago-
nists can ameliorate PV acantholysis in vivo and in vitro
(Nguyen et al. 2004b) and that local application of cholin-
ergic agonists such as pilocarpine had therapeutic eVect on
oral and skin lesions in PV patients (Iraji and YooseW 2006;
Namazi  2004). Cholinergic agonists increased protein
levels of Dsg 1, Dsg 3 and E-cadherin and antagonists to
cholinergic receptors resulted in keratinocyte dissociation,
which was paralleled by phosphorylation of these mole-
cules (Grando 2006a). Recently, a mechanism by which
signalling from cholinergic receptors could directly inter-
fere with PV-IgG-induced eVects was demonstrated. The
M1 mAChR agonist pilocarpine inhibited PV-IgG-induced
acantholysis by reducing serine phosphorylation of -cate-
nin and Src-mediated tyrosine phosphorylation of
p120catenin by activation of the speciWc protein phospha-
tases (Chernyavsky et al. 2007b). Similarly, an agonist of
the  7 nAChR reduced p120catenin phosphorylation both
on the level of Src activation as well as by activation of the
tyrosine phosphatase. Moreover, it was shown that M3 and
M4 receptors can lead to activation of Rho A and that car-
bachol, which activates  3 and  7 nAChR, activates Rho
A, Rac 1 and Cdc42 (Chernyavsky et al. 2004a, b; Ruiz-
Velasco et al. 2002), which also might be involved in the
inhibition of PV-IgG-induced acantholysis. Taken together,
these data indicate that activation of cholinergic receptors
could provide a promising strategy to treat PV patients.
Regulation of cell cycle and gene expression Recent data
support the hypothesis that PV-IgG change expression pat-
terns of molecules involved in cell cycle regulation and that
these molecules might be involved in acantholysis. As out-
lined above, PV-IgG-induced plakoglobin depletion
resulted in c-Myc overexpression in cultured keratinocytes
(Muller et al. 2008a; Williamson et al. 2006). Accordingly,
c-Myc overexpression was found in the epidermis of PV
patients, but interestingly not in PF skin, indicating that this
mechanism may only be important for PV (Williamson
et al.  2007,  2006). Because pharmacologic inhibition of
c-Myc as well as of plakoglobin degradation by blocking
GSK 3 abrogated pemphigus-IgG-induced skin blistering,
these results indicate that this mechanism could also be
important to induce acantholysis. However, the Wndings
that c-Myc overexpression was found after 24 h, whereas
PV-IgG-induced loss of cell aggregation was observed as
early as after 12 h and that c-Myc overexpression was
absent in PF skin indicate that c-Myc overexpression likely
contributes to ongoing proliferation of keratinocytes in PV,
whereas it seems not to be essential for acantholysis. There-
fore, other mechanisms must exist in addition to induce
keratinocyte dissociation. These mechanisms may, amongst
others, involve expression of genes diVerent from c-Myc,
which is suggested by the fact that plakoglobin deWciency
resulted in protection of keratinocytes from apoptosis, pos-
sibly via overexpression of the anti-apoptotic molecule Bcl-
XL (Dusek et al. 2007a).
Similar to c-Myc, cyclin-dependent kinase 2 (cdk2),
another kinase involved in the regulation of cell cycle pro-
gression, seems to be involved in keratinocyte proliferation
and acantholysis in pemphigus (Lanza et al. 2008). PV
serum increased protein levels of cdk2 and PV serum-
induced acantholysis in vivo was abolished by pharmaco-
logic inhibition of cdk2. Moreover, siRNA-mediated down-
regulation of cdk2 blocked cell dissociation in cultured
keratinocytes indicating that cdk2 may be important for PV
acantholysis in vivo and in vitro. However, at present, it is
unclear how continuing keratinocyte proliferation in conse-
quence to increased c-Myc and cdk2 signalling contributes
to acantholysis in PV.
One explanation is that reduced expression of desmo-
somal components in hyperproliferating cells may foster
the loss of keratinocyte cohesion in pemphigus. PV-IgG do
not only induce direct signalling eVects on cell junctions
and the cytoskeleton but also change gene expression pat-
terns, which may also contribute to pemphigus pathogene-
sis. It has been shown by DNA microarray that PV-IgG
within 8 h down-regulated transcription of 198 genes
including genes encoding for adhesion molecules including
Dsg 3 and desmoplakin, cytoskeletal proteins such as diVer-
ent cytokeratins as well as molecules involved in cell cycle
regulation such as p53 and cyclin D2 in cultured keratino-
cytes and that expression of some of these genes was anta-
gonistically regulated by methylprednisolone (Nguyen et al.
2004a). When PV serum was used for 24 h, the expression
of even more genes was altered. In cultured human kerati-
nocytes, transcription of 231 genes was decreased including
Dsc 2 and plakophilin 3 whereas transcription of 329 genes
was increased. In vivo, expression of 1114 genes wasHistochem Cell Biol (2008) 130:21–54 41
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reduced whereas transcription of 349 other genes was
inceased (Lanza et al. 2008). Pharmacologic inhibition of
cdk2 blunted the eVect of PV-IgG on the expression of
most of the genes including desmoplakin and also blocked
PV-IgG-induced acantholysis. Thus, it is conceivable that
altered desmosome formation may be involved in the
mechanisms underlying keratinocyte dissociation in
pemphigus.
Apoptosis Apoptosis has been detected in skin lesions and
in perilesional skin of PV and PF patients (Gniadecki et al.
1998; Puviani et al. 2003; Wang et al. 2004a) and hall-
marks of apoptosis such as DNA fragmentation, increased
expression of pro-apoptotic molecules Fas, FasL, Bax, p53,
depetion of anti-apoptotic Bcl-2 and FLIPL as well as acti-
vation of caspases 1, 3 and 8 have been observed following
treatment of cultured keratinocytes with PV-IgG or PV
serum (Arredondo et al. 2005; Baroni et al. 2004; Cher-
nyavsky et al. 2007a; Frusic-Zlotkin et al. 2005, 2006; Pel-
acho et al. 2004; Puviani et al. 2003; Wang et al. 2004a, b).
Hence, compelling evidence has been provided for the pres-
ence of programmed cell death in PV although the pheno-
type of acantholytic cells is diVerent from cells undergoing
apoptosis (Arredondo et al. 2005). However, for several
experiments prolonged incubation times of 48–72 h (Arre-
dondo et al. 2005; Baroni et al. 2004; Frusic-Zlotkin et al.
2005, 2006; Wang et al. 2004a, b) were required whereas in
most studies from the literature, acantholysis was clearly
present after 18–24 h (Berkowitz et al. 2006; Caldelari
et al. 2001; Lanza et al. 2008; Mahoney et al. 1999; Naga-
saka et al. 2004; Nguyen et al. 2000c; Shu et al. 2007; Spin-
dler et al. 2007; Takahashi et al. 1985; Tsunoda et al. 2003;
Waschke et al. 2005; Waschke et al. 2006; Williamson
et al. 2006). In another study, apoptosis was detected by
TUNEL reactivity starting after 6 h of PV-IgG treatment
(Chernyavsky et al. 2007a). However, in this study, loss of
intercellular adhesion was present after 120 min and thus
before onset of apoptosis. Therefore, it is conceivable that
apoptosis may be an event parallel to or in consequence of
acantholysis. On the other hand, it was reported that acti-
vated caspase 3 cleaves Dsg 3 (Weiske et al. 2001) and that
caspase and calpain inhibitors can block PV-IgG-induced
acantholysis in keratinocyte monolayers and in skin organ
culture (Arredondo et al. 2005; Wang et al. 2004a,  b;
Weiske et al. 2001). Taken together, it is unclear at present
to which extent PV-IgG-induced acantholysis is caused by
apoptosis.
Targets of signalling pathways in pemphigus
Pemphigus is a desmosomal disease because pathogenic
autoantibodies are directed against Dsg 1 and Dsg 3. More-
over, these antibodies result in the depletion of desmosomal
components from the cell surface, alterations of desmo-
somal plaques and a loss of desmosomes (Aoyama and Kit-
ajima 1999; Aoyama et al. 1999; Calkins et al. 2006; de
Bruin et al. 2007; Sato et al. 2000; Shu et al. 2007; Was-
chke et al. 2006; Williamson et al. 2006; Yamamoto et al.
2007a). However, it is unclear at present whether desmo-
somes are the primary targets of autoantibodies or whether
components outside of desmosomes cause disassembly of
desmosomes via mechanisms involving adherens junctions
or the cytoskeleton, which Wnally results in acantholysis.
The latter hypothesis is supported by the observation that
intercellular spaces between desmosomes widen before
desmosomes separate (Takahashi et al. 1985).
EVects on desmosomes and adherens junctions It is well
established that pemphigus autoantibodies lead to depletion
of desmosomal components from desmosomes as well as
from the cell surface. Within 30–60 min, PV-IgG induced
internalization and lysosomal degradation of cytoskeleton-
unbound Dsg 3 together with plakoglobin (Aoyama and
Kitajima 1999; Aoyama et al. 1999; Calkins et al. 2006;
Sato et al. 2000; Williamson et al. 2006; Yamamoto et al.
2007a). After 24 h, Dsg 3 but not Dsg 2, plakoglobin or
desmoplakin was also depleted from the cytoskeletal frac-
tions leading to reduced total cellular Dsg 3 levels (Calkins
et al. 2006; Yamamoto et al. 2007a). This eVect was medi-
ated by Dsg 3-speciWc antibodies because monoclonal Dsg
3 antibodies such as AK23 were eVective to induce Dsg 3
depletion and this eVect correlated with the pathogenic
activity of these autoantibodies in vivo and in vitro (Shu
et al. 2007; Yamamoto et al. 2007a). However, no strong
correlation between Dsg 3 depletion and keratinocyte dis-
sociation was observed. Dsg 3 depletion was observed in
DJM-1 cells at 40% conXuence as well as in normal human
keratinocytes. In contrast, in conXuent HaCaT monolayers,
a reduction of Dsg 3 half-life but no depletion of total cellu-
lar Dsg 3 was detected (Cirillo et al. 2006; Waschke et al.
2006). Because depletion of Dsg 3 was Wrst found in para-
llel with serine phosphorylation of Dsg 3, it was suggested
that phosphorylation might be required for Dsg 3 degrada-
tion (Aoyama and Kitajima 1999; Aoyama et al. 1999;
Bystryn and Rodriguez 1978; Rodriguez and Bystryn
1977). However, phosphorylation of Dsg 3 was observed in
some studies but not in others, which might be due to diVer-
ent cell culture models indicating that Dsg phosphorylation
is not necessary for acantholysis (Chernyavsky et al.
2007b; Nguyen et al. 2004a).
Some evidence exists that depletion of Dsg 1 may also
occur in pemphigus. However, studies to systematically
investigate Dsg 1 turnover in pemphigus are lacking. Dsg 1
internalization and decreased immunostaining of Dsg 1
have been observed following treatment with PF-IgG/-
serum and PV serum (Cirillo et al. 2007b; Waschke et al.42 Histochem Cell Biol (2008) 130:21–54
123
2005). This is in line with previous Wndings from the litera-
ture, which demonstrated that PF-IgG did not bind to kera-
tinocytes in the lower epidermis of PF patients but strongly
labelled basal keratinocytes in the epidermis of healthy sub-
jects suggesting that in PF the lower epidermis was
depleted from Dsg 1 (Bystryn and Rodriguez 1978; Rodri-
guez and Bystryn 1977). Taken together, it is unclear at
present to which extent Dsg depletion from desmosomes
causes  antibody-mediated acantholysis. However, even if
depletion of desmosomal components occured secondary to
keratinocyte dissociation, it likely would further aggravate
the loss of keratinocyte cohesion.
The involvement of adherens junctions in pemphigus
pathogenesis is unclear at present. It has been shown that
formation of adherens junctions is a prerequisite for desmo-
some assembly and -catenin-deWcient keratinocytes had
reduced numbers of desmosmes (Vasioukhin et al. 2000).
Because Rho GTPases are known to primarily regulate
adhesion mediated by classical cadherins in adherens junc-
tions whereas the requirement of Rho A and Rac 1 activity
for maintenance of desmosomal adhesion was reported just
recently (Braga and Yap 2005; Fukata et al. 1999; Spindler
et al.  2007; Waschke et al. 2006), it was suggested that
pemphigus IgG-induced inactivation of Rho A causes dis-
assembly of desmosomes via destabilization of adherens
junctions (Sharma et al. 2007). Although alterations of
adherens junctions in response to PV-IgG were negligible
compared to the eVects on desmosomes (Calkins et al.
2006; de Bruin et al. 2007; Muller et al. 2008a; Waschke
et al. 2006), this scenario cannot be completely ruled out at
present. In fact it was reported recently that PV-IgG lead to
phosphorylation of -catenin and p120catenin by PKC and
Src, respectively (Chernyavsky et al. 2007b). However,
more studies are required to address the question how cate-
nin phosphorylation in adherens junctions is associated
with keratinocyte dissociation in pemphigus.
EVects on the cytoskeleton Alterations of the cytoskele-
ton have been described both in pemphigus skin lesions as
well as in keratinocytes exposed to pemphigus autoantibod-
ies,. These eVects include dysorganization of cytokeratin
Wlaments, the actin cytoskeleton as well as of microtubules.
First, it has been described that cytokeratin Wlaments
become detached from cell junctions and accumulate in the
perinuclear region, a phenomenon commonly referred to as
“keratin retraction” (Berkowitz et al. 2005; Caldelari et al.
2001; Calkins et al. 2006; Chernyavsky et al. 2007a; Jinbu
et al. 1992; Kitajima et al. 1987; Waschke et al. 2006; Wil-
gram et al. 1961,  1964; Williamson et al. 2006). It was
shown that cytokeratin retraction could be detected as early
as 4–6 h after addition of PV-IgG, i.e. when Wrst alterations
of desmosomes became visible, and was fully established
after 24 h (Berkowitz et al. 2005; Calkins et al. 2006;
Chernyavsky et al. 2007a). However, because no cytokera-
tin Wlament reorganization was observed before cell detach-
ment and the desmosomes of acantholytic cells remained
anchored to cytokeratin Wlament bundles (Kitajima et al.
1986; Shimizu et al. 2004; Spindler et al. 2007), it appears
that cytokeratin retraction is not required for acantholysis
but may be a secondary event.
Recent studies demonstrated that acantholysis in pem-
phigus was paralleled by alterations of actin Wlaments
including increased stress Wber formation as well as frag-
mentation of actin Wlament bundles. Moreover, pharmaco-
logical inhibition of pemphigus IgG-induced acantholysis
also was eVective to reverse the eVects on the cytoskeleton
(Berkowitz et al. 2005; Spindler et al. 2007; Waschke et al.
2005; Waschke et al. 2006). Similarly, microtubule distri-
bution was found to be altered by pemphigus IgG (Kitajima
et al.  1986). Taken together, pemphigus IgG cause pro-
found cytoskeletal reorganization but it is unclear at present
whether these eVects contribute to acantholysis or are trig-
gered consequent to keratinocyte dissociation. Neverthe-
less, it is likely that alterations in the cytoskeleton may
account for the changes in cell shape during keratinocyte
dissociation, which seem to start between existing desmo-
somes (Bystryn and Grando 2006; Takahashi et al. 1985).
The role of the diVerent mechanisms in blister formation
As outlined above, both direct and indirect mechanisms
Wnally leading to a loss of desmoglein-mediated adhesion
have been found to be involved in pemphigus acantholysis.
At present, compelling evidence indicates that acantholysis
in PV and in PF is initiated by cellular signalling pathways
rather than by direct inhibition of Dsg binding (Fig. 11).
This was Wrst shown using plakoglobin-deWcient keratino-
cytes, which were resistant against PV-IgG-induced acan-
tholysis and was further supported by the Wndings that
inhibition of p38MAPK and activation of Rho A is suY-
cient to abolish PV-IgG and PF-IgG-induced skin blistering
(Berkowitz et al. 2005, 2006, 2007b; Caldelari et al. 2001;
Waschke et al. 2006). Moreover, low temperature-abro-
gated keratinocyte dissociation but not antibody binding to
the keratinocyte cell surface indicating that direct inhibition
of cadherin transinteraction by autoantibody binding is not
suYcient to cause acantholysis (Calkins et al. 2006). If
extracellular autoantibody-mediated direct inhibition of
Dsg binding would be the primary cause of acantholysis, it
is hard to imagine how this process should be blocked by
modiWed intracellular signalling or low temperature. It is
possible that antibody-mediated direct inhibition of Dsg
binding may contribute to trigger cellular signalling events
(Muller et al. 2008a; Sharma et al. 2007; Tsunoda et al.
2003). However, because PF-IgG were shown to induce
cellular signalling events but not to directly reduce Dsg 1Histochem Cell Biol (2008) 130:21–54 43
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binding, it seems that direct inhibition of Dsg transinterac-
tion is not essential to alter Dsg-mediated signalling (Heu-
pel et al. 2007; Waschke et al. 2005).
It is tempting to speculate that the clinical phenotype of
PV may be more severe compared to PF because additional
mechanisms could be involved in PV (Fig. 11). Indeed,
some mechanisms have only been found to contribute to
acantholysis in PV but not in PF. For instance, direct inhibi-
tion of Dsg 3 transinteraction was found in PV but not in PF
under conditions where antibodies caused acantholysis
(Heupel et al. 2007). Therefore, it is possible that direct
inhibition as a second pathway to reduce Dsg 3 binding in
PV may explain the more severe phenotype of PV. Simi-
larly, depletion of Dsg 3 has been convincingly shown in
PV whereas depletion of Dsg 1 in both PV and PF is less
clear (Yamamoto et al. 2007a). Moreover, altered plakoglo-
bin signalling leading to c-Myc overexpression was found
in PV patients’s skin but not in PF (Williamson et al. 2007,
2006). Other pathways have been investigated for PV only
whereas data for PF are lacking. As outlined above, inhibi-
tors of calmodulin, PKC, EGFR, cdk2 as well as of tyrosin
kinases have been shown to inhibit PV-IgG-induced acan-
tholysis.
Finally, it has to be emphasized that desmoglein proteo-
lysis, mechanical stress as well as secondary changes for
example in the extracellular Ca2+ concentration might con-
tribute to skin blistering. For instance, acantholysis may
foster skin blistering by derangement of the epidermal Ca2+
Fig. 11 The mechanisms in-
volved in pemphigus acantholy-
sis. Accumulating evidence 
indicates that PV-IgG and 
PF-IgG initiate keratinocyte 
dissociation via intracellular 
signalling pathways including 
p38 MAPK, Rho A and 
plakoglobin (PV only). In 
addition, other mechanisms such 
as direct inhibition of Dsg 3 
binding and Dsg 3 depletion 
from desmosomes as well as 
other signalling events seem to 
contribute to PV pathogenesis, 
whereas their role for 
acantholysis in PF is unclear. 
These mechanisms may account 
for the more severe clinical 
phenotype of PV compared to 
PF. PLC phospholipase C, PKC 
protein kinase C, cdk 2 
cyclin-dependent kinase 2, 
EGFR epidermal growth factor 
receptor44 Histochem Cell Biol (2008) 130:21–54
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gradient, which in turn would result in loss of desmosomal
cadherin binding, especially when the tight junctions of the
granular layer are aVected.
Concluding remarks
The major goal for the future is to elucidate the primary sig-
nalling pathways responsible for the diverse eVects of pem-
phigus IgG such as inhibition of desmoglein binding,
depletion of desmosomal components, loss of desmosomes,
reorganization of the cytoskeleton and Wnally the induction
of acantholysis. Other pathways will be identiWed to repre-
sent salvage mechanisms to rescue keratinocyte cohesion
(Grando 2006b). Moreover, future experiments may reveal
how the diVerent signalling pathways are involved in the
regulation of desmosomal adhesion in the speciWc epider-
mal layers. This knowledge may elucidate why the clea-
vage planes in PV and PF usually are diVerent. The second
goal is to characterize whether acantholysis in pemphigus is
caused by mechanisms directly targeting desmosomes or
whether cellular signalling pathways regulate desmosomal
adhesion via reorganisation of the cytoskeleton or via other
types of cell contacts such as adherens junctions.
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